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Abbreviation 
AC AT: Acyl-CoA acyltransferase 
BMN: Bombyx Mori insect cell line 
bp: base pair 
CAT: Chloramphenicol acetyltransferase 
CHO: Chinese hamster ovary cell line 
CHX: Cycloheximide 
Cos 7: African Green monkey kidney cell line 
dbCAMP: dibutyryl cyclic 3 丨，5 • -monophosphate 
FH: Familial hypercholesterolemia 
FSF: Human foreskin fibroblast 
HDL: High density lipoprotein 
HepG 2: Human hepatocellular carcinoma cell line 
HMG-CoA: 2-hydroxy-3-methylglutaryl Coenzyme A 
hLDLR: Human low density lipoprotein receptor 
HSV TK: Herpes simplex virus thymidine kinase 
LDL: Low density lipoprotein 
LDLR: Low density lipoprotein receptor 
LPDS: Low density lipoprotein deficiency serum 
PCR: Polymerase chain reaction 
PKC: Protein Kinase C 
PMA: Phorbol 12 - myristate 13-acetate 
PMSF: Phenylmethylsulfonyl fluoride 
R2-BF: Repeat 2 binding factor 
RTGH-1: Rat pituitary tumour cell line 
SC: Shanzha 
SRE: Sterol responsive element 
VLDL: Very low density lipoprotein 
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Abstracts 
A 5 kb recombinant reporter plasmid pLDLRP-GCAT-A was 
constructed by ligating 〜0.5 kb LDLR-promoter with 〜4.5 kb 
pGCAT-A reporter gene in order to characterize the LDLR-promoter 
in transfected HepG 2 cells by different drug treatment. The result, 
however, showed that CAT assay can only give a qualitative result in 
turning on or off of the reporter gene. 
Through gel-shift mobility assay, a specific DNA binding 
protein, named Repeat 2 binding factor (R2-BF), was identified in 
HepG 2 cell nuclear extract. Although the R2-BF showed no dose 
response in relation to different concentrations of LDL, it can be 
suppressed by incubating the cells with phorbol-12-myristate-13-acetate 
(PMA) and cycloheximide (CHX). This implies that the expression of 
R2-BF is non-responsive to LDL but is affected by protein kinase C 
phosphorylation. Moreover, the water extract of the Chinese herb -
Shanzha, can totally suppressed the expression of R2-BF. Since 
Shanzha can also up regulates LDLR expression in the presence of % 
LDL, its action on R2-BF may be the underlying mechanism by which 
it affects the expression of LDLR gene. 
A cDNA library of HepG 2 cells was constructed to clone the 
specific Repeat 2 binding protein. Unfortunately, no positive clone has 
been identified so far. 
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1.1 Historical background in the studies of LDL and 
LDLR 
The study on LDLR and its regulation can be traced to the 
disease Familial hypercholesterolemia (FH) in the thirteenth century. 
FH is a genetic disease and patients suffering from it carry a single 
copy (heterozygote) or both copies (homozygote) of the mutated LDLR 
gene. FH was first described in 1983 by Carl Miiller as an "inborn 
error of metabolism" that was characterized by high blood-cholesterol 
and prematured myocardial infarction in young people. 
The major component of LDL is cholesterol. Scientists who 
explored the structure of cholesterol were awarded the thirteenth Nobel 
Prize. The major classes of human plasma lipoproteins were delineated 
in the 1950,s and 1960's through the efforts of many laboratories. In 
the 1970、，Goldstein and Brown's group had postulated that FH may 
result from a failure of end-product repression of cholesterol synthesis. 
Their studies led to the discovery of a cell surface receptor for the 
plasma cholesterol transport protein LDL. And subsequently they were 
able to work out the mechanism by which this receptor mediates 
feedback control of cholesterol synthesis. Through the discovery of the 
receptor-mediated pathway for cholesterol homeostasis, Brown and 




Since then, the scope in studying LDLR was turned to the 
molecular level. The whole sequence of human LDLR was determined 
by Yamamoto et al (1984). In 1987，Goldstein and Brown (Siidhof et 
al’ 1987a) identified a 177 bp fragment in the LDLR promoter which 
contained the signals for expression as well as negative regulation by 
sterol. The 177 bp fragment contains 3 direct repeats and 2 TATA-like 
sequences. The direct repeats are homologous to the consensus 
sequence recognized by the eukaryotic transcription factor Spl which 
may play a role in the expression of the L D L receptor gene. In 
addition, Siidhof also identified a 42 bp element in the 5'-flanking 
region of the L D L receptor gene, designated sterol responsive element 
(SRE)，which contained two 16 bp direct repeats that exhibit positive 
and negative transcriptional activities (Siidhof et al，1987b). The SRE 
is believed to be responsible for controlling gene expression in a sterol • 
responsive manner. From studies on the mutant hLDLR-promoter, 
Dawson et al (1988) showed that Repeat 3 is a constitutive positive 
transcriptional element that acts in the absence or presence of sterols. 
On the other hand, Repeat 2 conferred strong repression upon Repeat 3 
when sterols were present (Dawson et al，1988). They suggested that 
LDLR is regulated by sterol-regulated binding protein to Repeat 2 
which silences the activity of the adjacent Spl-binding site in Repeat 3. 
By using substitution mutagenesis, Smith et al (1990) delineated that 
the central 10 nucleotides of Repeat 2 are crucial for sterol regulatory 
activity. Substitutions within the 10 bp sequence in Repeat 2 largely 
prevented the induction of transcription, which occurred in the absence 
of sterols. They found that the SRE of the LDLR promoter is a 
conditional positive element that co-operates with other elements to 
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enhance transcription in the absence of sterols and loses its function in 
the presence of sterols. 
Recently, a SRE - nuclear binding factor was identified in 
Chinese Hamster Ovary (CHO) cell nuclear extract that binds to the 
SRE-1 octanucleotide sequence (Stark et al, 1992). It is suggested that 
there may be a nuclear protein that binds onto the c/5-acting element in 
the LDLR-promoter to alter the transcription of that gene. In this 
respect, Auwerx et al (1989b) found that when THP-1 cell and HepG 2 
human hepatocarcinoma cell were grown in phorbol-12-myristate-13-
acetate (PMA) or cycloheximide (CHX), super induction of LDLR and 
2-hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) reductase genes 
were observed. It is hypothesized that protein kinase C may act 




1.2 Homeostasis of Cholesterol in Man 
1.2.1 Origin and catabolism of low density lipoprotein 
Cholesterol is a Janus-faced four-ring complex structure and it is 
synthesized from a simple two carbon substrate (acetate) through the 
action of at least 30 enzymes. Scientists have been fascinated with 
cholesterol because of its essential function in membrane of animal 
cells, where it modulates fluidity and maintains the barrier between the 
cell and its environment, and its role as the raw material for steroid 
hormones and bile acids. However, i f cholesterol accumulates in the 
wrong place such as the wall of an artery where it cannot be readily 
mobilized, it can accelerate the formation of atherosclerotic plaques, 
leading to heart attacks and strokes. 
The plasma lipoproteins are a family of globular particles, each 
of which consists of a core of neutral lipid (triglyceride of cholesteryl 
ester) surrounded by a coat of phospholipid and protein. They include 
the chylomicrons, which primarily transport dietary triglyceride and 
cholesterol; the very low density lipoprotein (VLDL), which primarily 
transports triglycerides that have been synthesized in the liver; and two 
lipoproteins that function primarily in the transport of endogenous 
cholesterol, called low density lipoprotein (LDL) and high density 
lipoprotein (HDL). LDL is the major cholesterol-carrying lipoprotein 




L D L particles can be isolated from human serum by 
ultracentrifugation in the density range 1.019 _ 1.063 g/mL. They have 
a molecular weight ranging from about 2 to 3.5 X 10^ and diameters 
from 200 to 250 A (Gofman et al, 1949, Lindgren, 1975). The protein 
component of LDL is apoprotein B with a molecular weight of 500,000 
daltons per particle of LDL. The lipid component of LDL consists 
primarily of an apolar core of neutral lipid mostly of esterified 
cholesterol, with a phospholipid and free cholesterol coat surrounding. 
It is thought that the apoprotein B subunits form globules, part is buried 
in the lipid core and part is exposed at the water surface. 
The apoprotein-B component of plasma LDL is known to be 
synthesized in two tissues, the liver and the intestine. Apoprotein B is 
secreted into the plasma by the liver as part of a triglyceride-rich 
lipoprotein particle, VLDL, that also contains various other proteins. 
After its secretion by the liver, the VLDL particle is transported to the 
adipose tissue where its triglycerides are removed through the action of 
the enzyme lipoprotein lipase. In association with the removal of 
triglycerides, all peptides other than apoprotein B leave the VLDL 
particle and the cholesteryl ester content of the particle increases, 
presumably through the action of the plasma enzyme 
lecithin: cholesterol acyltransferase, which esterifies cholesterol by 
transferring a fatty acid from the 2-position of lecithin to cholesterol. 
When nearly all of the triglycerides have been removed and the 
cholesteryl esters have increased sufficiently, VLDL becomes a LDL 
particle (Goldstein and Brown, 1977). 
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1.2.2 The LDL receptor 
The bovine LDL receptor was purified from bovine adrenal 
cortex by Russell et al in 1983. Partial amino acid sequence of the 
receptor was used by Yamamoto et al (1984) to isolate a fall-length 
complementary DNA for the human LDL receptor. In normal person, 
there is a single copy of LDL receptor gene on chromosome 19 which 
is 45 kilo-bases long. There are 5 domains in the LDL receptor and 
the first, fourth and fifth domain of the receptor are believed to be 
critical for it's normal fiinction. At the N-terminal of the receptor, 
there is a hydrophobic sequence of 21 amino acids that is cleaved from 
the receptor immediately after it is translated. It is a typical signal 
sequence to direct the nascent receptor to the ER membrane. The 
mature L D L receptor consists of 839 amino acids (Yamamoto et al 
1984). 
The first domain of the LDL receptor consists of 292 amino 
acids and there are 7 repeats of a 40 amino acids sequence containing 6 
convoluted cysteine disulphur bonding. This region is believed to be 
responsible for the binding of LDL. The second domain consists of 
400 amino acids and has a 35% homology to EGF precursor. 
However, the ftinction of this domain is still unknown. The third 
domain of the LDL receptor lies immediately external to the 
membrane-spanning domain and consists of 58 amino acids and this 
region contains a cluster of O-linked sugar chains. The fourth domain 
consists of a stretch of 22 hydrophobic amino acids that span the 
plasma membrane. The fifth domain is the cytoplasmic tail with the 
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COOH-terminal segment of 50 amino acids that projects into the 
cytoplasm. The tail is important for receptor clustering to form coated 
pits for invagination. 
The LDL receptor is a cell surface glycoprotein that contains 
approximately two asparagine-linked (N-linked) oligosaccharide chains 
of the complex type and approximately 18 serine/threonine-linked (O-
linked) oligosaccharide chains. The LDL receptor binds two proteins: 
the apo B-lOO which is a 400,000 daltons glycoprotein that is the sole 
protein of LDL; secondly, the apo E which is a 34,000 daltons protein 
that is found in multiple copies in intermediate density lipoprotein 
(IDL) and a subclass of HDL (Brown and Goldstein, 1986). 
1.2.3 LDL pathway 
About 45 minutes after synthesis from endoplasmic reticulum, 
the L D L receptors appear on the cell surface, where they gather in 
coated pits. Once they are formed, the coated pits invaginate to form 
coated endocytic vesicles. Then multiple endocytic vesicles fuse to 
create larger sac, called endosomes. The pH of the endosomes quickly 
falls below 6.5 because of ATP-driven proton pumps in the membrane. 
At this acidic pH, the LDL dissociates from the receptor. The LDL 
receptor then returns to the surface to form a recycling vesicle. Once 
L D L receptor reaches the surface, the receptor binds another LDL 
particle and starts another cycle of endocytosis (Brown and Goldstein, 
1986). The LDL receptor makes one round trip into and out of the cell 
every 10 minutes for a total of several hundred trips in its 20 hour life-
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span (Brown, Anderson and Goldstein, 1983). 
Inside the endosome the protein component of LDL are 
hydrolyzed to amino acids and cholesteryl esters to cholesterol. When 
there is an excess of cholesterol it wil l be re-esterified by acyl-CoA 
acyltransferase (ACAT) to form cholesterol ester and store as 
irregulate shape cholesteryl ester droplet. The level of cellular 
cholesterol is believed to be one of the regulatory elements in the 
expression of LDL receptor (see Figure 1.1). 
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Figure 1.1 
Sequential steps in the LDL receptor pathway of 
mammalian cells. Vertical arrows indicate the 
regulatory effects on particular protein. 
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1.2.4 Feedback regulatory action of LDL receptor 
Cellular cholesterol homeostasis is mainly maintained by sterol-
mediated feedback repression of genes whose products mediate the 
uptake of exogenous cholesterol and the synthesis of cholesterol within 
the cell. When cells accumulate excess sterol they suppress the uptake 
of exogenous sterol through repression of the gene for low density 
lipoprotein receptor (Siidhof et al, 1987a). The cholesterol released 
from L D L migrates into the cytoplasm and elicits a regulatory response 
that maintains cholesterol homeostasis inside the cell. When fibroblasts 
are grown in medium supplemented with LDL, the cells are protected 
from over accumulation of cholesterol by suppression of its own 
cholesterol synthesis. The suppression of its own cholesterol 
biosynthetic pathway is achieved by retardation of enzyme activity of 3-
hydroxyl-3-methylglutaryl (HMG) Coenzyme A reductase (Osborne, 
1985) and 3-hydroxyl-3-methylglutaryl Coenzyme A synthase (Gil et 
al, 1986). And the inhibition of HMG-Co-A reductase activity is 
believed to be due to a retardation in the rate of synthesis of the 
enzyme and the cholesterol derived from LDL is responsible for 
I 
regulating this inhibition (Brown, et al, 1974). Also, the cholesterol 
derived from LDL can also stimulate the synthesis of microsomal 
enzyme AC AT. The AC AT can re-esterify the cholesterol to form 
cholesteryl esters and stored them in the cell (Brown et al” 1975). 
Besides, when the cholesterol level is high in the cell, the expression of 
L D L receptor on the cell surface would be suppressed. Through these 
regulatory processes, cells obtain cholesterol by endogenous synthesis 
and uptake from exogenous lipoprotein during periods of cholesterol 
10 
• Introduction. 
demand, and they avoid over accumulation of cholesterol when the 
demand has been satisfied. The mechanisms on the sterol-mediated 
feedback repression of genes and wil l be discussed in the following 
section. 
1.3 Gene structure of LDL receptor promoter 
1.3.1 The LDL receptor promoter 
The L D L receptor promoter is about 0.68 kb long (see Appendix 
1) with three 16 bp. imperfect direct repeats which are designated as 
Repeat 1 (from -81 to -96), 2 (from -45 to -61) and 3 (from -128 to -
144). Two TATA-like region are located at -101 to -107 and -110 to -
116 (Siidhof et al, 1985). Al l sequences are located within 100 bp from 
the start site of mRNA synthesis (see Figure 1.2). 
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Figure 1.2 
Low denisty lipoprotein receptor upstream regulatory structure 
and sequences of Repeat 1，2 and 3. 
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1.3.2 The responsive element in LDL receptor promoter 
In order to study the functional role of promoter, a CAT reporter 
gene is usually connected to the downstream region of the promoter 
interested. The reporter gene product was then extracted to determine 
the level of expression. The potency of the promoter is normally 
determined by comparing different promoter-reporter gene structure 
(Alam and Cook, 1990). 
Generally, the control of the expression of L D L receptor is 
mainly by c/5-acting elements in the 5'-flanking region that contains 
both positive and negative regulatory sequences. Through the creation 
of deletion mutants, a 177 bp fragment of the 5'-flanking region of the 
L D L receptor was first identified to be sufficient for expression as well 
as an negative regulation by sterols (Siidhof et al，1987a). The 
functional element in the promoter was further narrowed down to a 42 
bp region of the LDLR-promoter that included Repeat 2 and 3. This 
fragment was inserted immediately upstream of the TATA box in the 
herpes simplex virus thymidine kinase promoter (HSV TK) which in 
turn was used to drive a CAT gene. When transfected into CHO cells, 
this construct produced CAT transcripts that were suppressed by 
sterols. Because of this property, this 42 bp sequence was named 
Sterol Responsive Element (SRE) of the LDL receptor (-127 to -169) 
(Siidhof et al, 1987b). 
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By analysis of promoter mutants, current information indicates 
that the L D L receptor is repressed by sterol through a push-pull 
mechanism mediated by Repeat 2 and 3 (see Figure 1.2). Repeat 2 
differs from Repeat 1 and 3 at the sixth and fourth nucleotide position 
and it does not bind Spl. When Repeat 2 was inserted into the HSV-
TK promoter, it elicited a high level of expression of a reporter gene 
only in the absence of sterols. This enhancing effect was lost when 
sterols were present. On the other hand, insertion of Repeat 1 and 3 
into the HSV-TK construct enhanced transcription even in the presence 
of sterol. The "real" sterol responsive element has been localized to a 
16 bp sequence inside Repeat 2 (Siidhof et al, 1987b and Dawson et al, 
1988). When several individual nucleotides within Repeat 2 were 
mutated, sterol regulation was prevented. This implies that a 
sequence-specific DNA-binding protein may be involved in sterol-
mediated repression of LDLR. Moreover, by deletion or scramble 
mutation of Repeat 2 and 3，very little or no transcription of the fusion 
reporter gene as well as the sterol responsive regulation could be 
observed (Siidhof et al’ 1985). Apparently, Repeat 2 and 3 exert a 
positive effect on transcription in the absence of sterol and this activity 
is reduced when sterols are present. However, Repeat 3 by itself has 
positive transcriptional activity, but it is not able to confer repression 
by sterol (Siidhof et al, 1987b and Dawson et al, 1988). 
In conclusion, Repeat 1 and 3 are a positive transcriptional 
elements while Repeat 2 silences the activity of Repeat 3 when sterols 
are present (Dawson et al, 1988). 
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1.4 Eukaryotic transcription factor 
It is well established that the primary control of gene expression 
lies at the level of gene transcription. Many genes are known to be 
transcribed only in a specific tissue where their protein products are 
required (Mitchell and Tijan, 1989 and Levine and Manley, 1989). 
Genes which are regulated in parallel in response to a particular 
inducing signal or in a particular tissue have been shown to contain 
common DNA sequence elements which are often but not always 
located up-stream of the start site of transcription. These elements play 
a crucial role in the specific expression pattern of such genes. Thus 
their destruction by mutation results in the abolition of the specific 
. pattern of gene expression whilst their transfer to a marker gene 
confers this pattern of regulation on the heterologous gene. The 
control region in the immediate vicinity of a transcription start site is 
called the promoter; regions that regulate a promoter from a distance 
and in an orientation-independent fashion are called enhancers. 
It is believed that such DNA sequence elements would act by 
binding specific regulatory proteins, called transcription factors. In 
recent years, there are a number of transcription factor isolated and 
characterized (Steffen and Meyer, 1992). These transcription factors 
would interact with each other to modulate transcription. The study of 
such transcription factors has been very difficult, because they are 
present in very small amount. Hence, even when they were purified, 
only limited amounts were obtained which were insufficient for detailed 
biochemical study of the functional properties of these proteins. 
15 
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The first essential feature that such factors require is the ability 
to bind to DNA in a sequence specific manner. Following such 
binding, the factor must interact with other factors or with RNA 
polymerase in order to influence transcription either positively or 
negatively. Finally, in the case of factors which regulate transcription 
in response to a particular stimulus or in a particular tissue, some 
means must exist to regulate the synthesis or activity of the factor so 
that it is only active in the correct situation. There are several 
mechanisms proposed that can repress or activate the transcription of 
gene. For repression of gene transcription, competition, squelching, 
quenching and direct repression have been proposed. For activation of 
gene transcription, direct activation in the presence of transcription 
factor, ligand binding, dissociation of an inhibitory protein and protein 




1.5 Role of Gel-shifted assay in studying DNA binding 
protein 
To understand gene expression at the molecular level, the study 
of interactions between nucleic acids with a wide variety of sequence-
specific regulatory proteins is required. Generally speaking, gene 
transcription in eukaryotes is controlled by the binding of nuclear 
proteins to DNA sequence elements termed promoters and enhancers. 
Proteins binding to specific sequences within such elements probably 
interact with one another and with RNA polymerase and its associated 
transcription factors to facilitate the initiation of transcription. 
Identification of sequence-specific DNA-binding proteins constitutes a 
key step towards elucidating the processes that regulate transcription. 
In order to identify and characterize such sequence-specific DNA-
binding proteins, techniques have been developed to detect their 
presence in nuclear or whole cell extracts. The simplest and most 
sensitive way is the gel retardation method in which a labeled DNA 
fragment containing the sequence of interest is mixed with the proteins 
and the mixture is then analyzed by polyacrylamide gel electrophoresis. 
Alternative terms used to describe this type of method are 'Gel shift' or 
'Gel mobility shift' analysis. Gel shift analysis has been especially 
useful in searching for DNA binding proteins (e.g., transcription 
factors) in crude extracts from eukaryotic cells (Steffen and Meyer, 
1992). A number of recent reviews on the gel-shift assay have been 
published (Revzin, 1989，Ramanujam Ponnusamy et al, 1990，Lane et 
al，1992). A remarkable amount of information could be deduced from 




The Gel-shifted assay consists of a mixture of 32p end labeled 
DNA target sequence, protein extract, non-specific DNA molecules 
and binding buffer. After incubation at appropriate conditions, the 
assay mix is then placed into the well of a polyacrylamide or agarose 
gel. The assay is based on the differential migration of free nucleic 
acid and protein-bound nucleic acid. During electrophoresis the free 
DNA molecules rapidly enter the gel as a band, and physically separate 
from the other components while the DNA-protein complexes are 
retarded and migrate at a slower speed. I f the complexes are 
sufficiently stable this band wil l persist throughout the electrophoresis 
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Figure 1.3 
Principle of gel shift assay. 
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1.6 Objective of the present thesis 
In this thesis, I aim to investigate the mechanism of LDLR 
regulation at the gene level. As LDLR is the major pathway through 
which serum cholesterol is removed by the liver, examination of the 
mechanisms on how this receptor is regulated would yield insights on 
designing means to enhance the removal of cholesterol from the 
bloodstream. 
It is generally accepted that LDLR is under a negative regulation 
by L D L . An increase in serum L D L would lead to a reduction in total 
cell surface receptor while a decrease would result in an opposite 
response. Since, the protein synthesis inhibitor, cycloheximide, 
prevents the down regulation of LDLR (Auwerx et al, 1989a，Mazzone 
et al, 1989)， it is possible that L D L can trigger some kind of 
intracellular signal(s) and that the control of expression of LDLR gene 
may involve negatively regulatory protein(s). The entry of L D L into 
the cell may interact either directly or indirectly to this regulatory 
protein(s) resulting in turning on or off the receptor gene. Gel-shift 
assay was employed in order to identify and characterize the specific 
DNA-binding protein which may control the gene expression of LDLR. 
In the long run, i f the mechanism of LDLR regulation can be 
worked out, we can design better means in up regulating them so that 
cholesterol can be removed from the bloodstream of 
hypercholesterolemic subjects more efficiently. 
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Chapter 2 
Materials and Methods. 
2.1 Oligonucleotide synthesis and purification 
Al l oligonucleoties used in this thesis were synthesized by the 
Applied Biosystem 391 PCR-MATE and purified by the OPC column 
purification scheme (Applied Biosystem). 
2.1.1 Primer construction 
Primer 624A (5'-TTTTT GGATC CTGAT TGATC AGTGT 
CTATT AGGTG-3') and Primer 58B (5'-CCCCC GAGCT CTGGA 
AACCC TGGCT TCCCG CGATT GC-3') were constructed according 
to the sequence of human low density lipoprotein receptor promoter -
624 to - 58 base pair region (Siidhof, 1985) (see Appendix 1). BamHI 
cutting site (underline) was created at the 5•-end of Primer 624A with 
5 thymidine cramping site and Sac I cutting site (underline) was created 
at the 5•-end of the Primer 58B with 5 cytosine cramping site. 
16 bp a/?"-sense Repeat 2 (5丨-GCAGT GGGGT GATTT T-3') 
and sense Repeat 2 (5,-AAAAT CACCC CACTG C-3') 
oligonucleoties were constructed according to the sequence of human 
L D L receptor promoter -145 to -161 (Siidhof, 1985). 
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Scramble mutated 16 bp a树/-sense Repeat 2 (5'-GCGCA 
TAGGT GATTT T-3') and scramble mutated 16 bp sense Repeat 2 (5'-
A A A A T CACCT ATGCG C-3') were constructed according to Siidhof 
et al, (1987b) who have proven that this sequence was inactive in sterol 
response. 
I 
A randomly selected 18 base sense strand EPO primer (5'-ATC 
ACT GTC CCA GAC ACC - 3') and a 17 base a胁-sense strand EPO 
reverse primer (5，-GGT GTC TGG GAC AGT G-3') were synthesized 
by standard procedures. 
2.1.2 Purification of oligonucleotides 
After the synthesis of a deoxyoligonucleotide in the DNA 
synthesizer, the DNA produced was not biologically active yet. 
Phosphate groups and base exocyclic amines were inserted during 
synthesis to prevent side reactions. Following synthesis, these 
protecting groups had to be removed. There are three types of 
protecting groups: 5' protecting group-dimethoxytriyl (DMT), P-
cyanoethyl phosphate protecting groups, and base protecting groups-
benzoyl on dA and dC and isobutyryl on dG. 
After the completion of synthesis, the column was removed from 
the instrument. Oligonucleotides were simultaneously 
decyanoethylated and cleaved from the support using concentrated 
ammonium hydroxide. The base protecting groups were removed next 
by the addition of fresh concentrated ammonia and incubating at 55^C 
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overnight. The oligonucleotide solution was diluted 1 : 3 with 
autoclaved distilled water and then loaded directly on an OPC cartridge 
(ApplyBiosystem 400771). 
The OPC cartridge was first equilibrated by 5 mL HPLC grade 
acetonitrile followed by 5 mL 2.0 M triethylamine acetate. The 
ammonium hydroxide-DNA solution was diluted 3 folds with deionized 
water and loaded into the OPC cartridge gently. The unabsorbed 
materials were pooled and stored at The cartridge was flushed 
three times with 5 mL of diluted ammonium hydroxide, two times with 
5 mL deionized water, 5 mL 2% trifluoroacetic acid solution and two 
times with 5 mL deionized water. Finally, the oligonucleotides were 
eluted by flushing with 1 mL 20% acetonitrile solution. The DNA 
solution was dried by Speed vac. The amount of DNA obtained was 
quantified by absorption at OD26O. 
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2.2 Recombinant plasmid construction 
2.2.1 Preparation of competent cell 
One percentage overnight culture of E. coli JM 109 was 
inoculated in 12 mL SOB medium (20 g Bacto-tryptone, 5 g Bacto-
yeast-extract, 0.5 g NaCl in 1 L distilled water supplemented with 10 
m M MgCl2) and incubated at 370C for 3 - 5 hours until the ODgQO > 
0.6. The cells were spun down at 5,000 rpm at resuspended in 
10 mL TFB (10 mM MES-KOH pH 6.3，45 mM MnCl2.4H20，10 
m M CaCl2.2H20, 100 mM KCl, 3 mM Hexamminecobalt chloride) 
and chilled on ice for 10 minutes. Cells were then spun down again, 
resuspended in 0.8 mL TFB and 28 |LIL DnD (filtered to sterile 1.53 g 
Dithiothreitol, 9 mL DMSO, 100 juL 1 M Potassium acetate with pH 
7.5，10 mL distilled water) and were chilled for 10 minutes and 
another 28 |LIL DnD was added. At this point, the competence cells 
were ready for use in the transformation. 
2.2.2 Preparation of phage DNA 
The cloned human low density lipoprotein receptor gene was 
obtained from American Type Culture Collection (ATCC: 57246). 
The freeze-dried phage lysate was re-hydrated by adding 1 mL of SM 
buffer (50 mM Tris-HCl, 100 mM NaCl, 8 mM MgS04，0.01% 
gelatin with pH 7.5). The phage suspension was diluted (102 to 109 
folds) in order to titre the concentration of phage. 
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100 ^iL diluted phage lysate and lOOjuL E. coli LE392 were 
mixed and placed at 37^0 incubator for 20 minutes. 3.5 mL of 0.5% 
top agar with 10 mM MgSOj was added to the phage-bacteria 
suspension. The top agar was vortexed and poured on to a LB plate 
(10 g Bacto-tryptone, 5 g Bacto-yeast-extract, 10 g NaCl in 1 L 
distilled water supplemented with 1.2% agar) and spread evenly. The 
phage was allowed to grow at 370C for 7 -12 hours so as to obtain a 
confluent lysis. 
Five to six plates (90 mm) of 100% confluent lysis were used in 
the purification of phage DNA. 2.5 mL SM buffer was added to the 
surface of the top agar. The plates were then shaken at 37^0 for at 
least 30 minutes. The SM buffer was aspired and kept in sterile 
centrifuge tube. Chloroform was added to 0.3 %. The bacterial cell 
debris was spun down at 5000 rpm. Rnase A (10 jug/mL final) and 
Dnase I (1 |xg/mL final) were added to the supernatant and incubated at 
370c for at least 30 minutes. An equal volume of phage precipitation 
solution (20% W/V polyethylene glycol 6000-8000，2M NaCl) was 
added and the mixture was placed at O^C for at least 1 hour. 
Afterwards, the supernatant was subjected to centrifiigation at 10,000g 
(Hitachi rotor no. 20-2) for 20 minutes. After the removal of the 
last drop of supernatant, 1 mL SM buffer per 10 mL initial volume was 
added and vortexed gently. Again, it was subjected to centrifiigation at 
8,000g at for 2 - 5 minutes. The mixture was extracted two times 
with equal volume of TE-saturated phenol/chloroform (49:1) and 
followed by one time chloroform : isoamylalcohol (24:1). Then equal 
volume of isopropanol was added and placed at -70^C for at least 20 
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minutes. Phage DNA was collected by centrifuged at 12，000g for 10 
minutes at and after drying and it was re-dissolved in 100 jiiL TE 
buffer (10 mM Tris-HCl with pH 8.0). The DNA solution was 
quantified by running oji a 0.8% TBE (10.8 g Tris-base, 5.5 g boric 
acid，4 mL 0.5 M EDTA (pH 8.0) in one liter distilled water) agarose 
gel with X Hind I I I as marker. 
2.2.3 Amplification and purification of LDLR-promoter 
by PCR techniques 
2.2.3.1 Amplification and restriction site construction 
of LDLR-promoter 
The human cloned LDLR-promoter was amplified by PCR. The 
cloned phage DNA, which contained the LDLR-promoter, was first 
subjected to cutting with restriction enzyme Eco RI, Then 1.0 jiiM of 
Primer 624A and 58B (Figure 3.2) was added to a 0.5 mL microfuge 
tube along with template phage DNA (either cut or uncut with Eco RI) 
in a quantity of < 10 fig per tube, 10 ^ L ten times PCR buffer, 200 ju 
M dNTP's mix and 2.5 units of AmplitaqTM DNA polymerase (Perkin-
Elmer Cetus). The reaction mixture was made up to 100 juL by 
sterilized double distilled water. The negative control PCR reaction 
was the same as above except the DNA template was substituted by 
sterilized double distilled water. Al l the samples were then denatured 
at 940c for 2 - 3 minutes. PCR was performed as follows: 94^0, 2 
minutes for denaturation; 50^C, 2 minutes for annealation and 2 
minutes at 74^C for polymerization. The cycle was repeated 30 times. 
At the end of the reaction, the mixture was kept at 74^C for 10 minutes 
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to ensure complete polymerization. Aliquots of PGR products were 
identified by running a 0.8% TBE agarose gel. 
2.2.3.2 Purification of the PCR product 
4 
The LDLR-promoter generated by PCR was purified by using 
the GENECLEAN Kit (Bio 101). 
PCR product was first separated in a 1% TAE agarose gel (Tris-
Acetate). The band of interest (a 566 bp PCR product) was cut under 
long wavelength UV lamp and placed in a 1.5 mL eppendoff tube. 1.2 
mL of sodium iodide was then added. The mixture was incubated at 
550c for 5 minutes until the agarose melted. 15 juL of GLASS MILK 
was added and the tube was placed on ice for 2 minutes. The GLASS 
MILK was washed three times with 300 |LIL diluted NEW WASH. 
Finally, the PCR product was eluted 2 times with 15 j iL sterilized 
double distilled water at 55^C for 2 minutes. The amplified LDLR-
promoter was subjected to cutting with restriction enzyme Bam HI and 
Sst I (Sac I isoschizomer). Aliquot of the cut product was self-ligated 
in order to confirm the existence of the restriction site. 
2.2.4 Preparation of plasmid pGCAT-A 
A 200 mL overnight culture of E. coli JM 109 containing the 
reporter vector pGCAT-A (Appendix 2) was used for plasmid 
preparation. pGCAT-A was purified by Qiagen tip-100 (Qiagen) and 
the procedures done according to the manufacturer's instruction. 
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Bacteria were first spun down at 5000 rpm and the supernatant 
was discarded. 4 mL PI (50 mM Tris-HCl, 10 mM EDTA, 100 jug 
Rnase A/mL with pH 8.0) was added to resuspend the bacteria. Then 
4 mL P2 (200 mM NaOH, 1% SDS) was added with gentle stirring in 
order to lyse the bacteria thoroughly, and 4 mL P3 (2.55 M potassium 
acetate with pH 4.8) was added to precipitate the bacterial debris. The 
mixture was centrifiiged at 12,000g (Hitachi rotor no. 20-2) for 30 
minutes at Next, the supernatant was carefully aspired and kept 
in a sterile centrifugation tube and spun at 12,000g for a further 10 
minutes at . The supernatant was carefully withdrawn and kept at 
40c. 
• 
The Qiagen tip-100 column was equilibrated with 5 mL QBT 
(750 mM NaCl, 50 mM MOPS, 15% ethanol with pH 7.0). The 
supernatant obtained previously was then loaded onto the column. The 
unabsorbed material was saved. The tip was then washed two times 
with 5 mL QC (1.0 M NaCl, 50 mM MOPS, 15% ethanol with pH 
7.0). Plasmid was eluted with 5 mL QF (1.25 M NaCl, 50 mM 
MOPS, 15% ethanol with pH 8.2). The elution was repeated once to 
insure that all the plasmid had been eluted. 
The elutant was pooled and 0.7 volume (7 mL) of isopropanol 
was added to precipitate the plasmid DNA. The plasmid was 
centrifiiged at 13,000g 30 minutes at Then the plasmid pellet was 
washed 2 times with 70% ethanol and dried in vacuum (Speed-Vac). 
The dried plasmid pellet was re-dissolved in 1 mL TE (pH 8.0) buffer. 
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Finally, the plasmid was quantified by running in a 0.8% TBE agarose 
gel after cutting with Bam HI and Sst L 
2.2.5 Recombinant plasmid pLDLRP-GCAT-A 
construction 
Recombinant plasmids were constructed by standard techniques 
(Sambrook, Fritsch, & Maniatis，1989) and their structures were 
verified by DNA sequencing and restriction mapping. pLDLRP-
GCAT-A was prepared by ligating the LDLR-promoter generated by 
PCR (see Section 2.2.3.1) to the pGCAT-A reporter plasmid between 
the BamH I and Sac I site (Freburg and Brison, 1988). pGCAT-A 
carries a copy of the gene coding for chloramphenicol acetyltransferase 
(CAT). Two to one PCR insert to vector ratio was used in the ligation 
reaction. 100 ng insert was added to a 1.5 mL microfuge tube along 
with 50 ng of plasmid vector. 1.5 | iL of ten times ligation buffer and 1 
|liL of ligase (New England Biolab) were then added. Ligation was 
performed at 16^C for at least 6 hours. 
2.2.6 Transformation of DNA to competent cell 
210 |LIL of competence cell (E. coli JM 109) (Section 2.2) was 
added to the ligation mixture (100 ng). The mixture was vortexed and 
chilled on ice for 1 hour. Then the mixture was heat shock at 42^C 
for exactly 2 minutes and chilled on ice for 2 minutes. After that, 800 
^iL SOC (SOB supplemented with 20 mM glucose) was added to the 
mixture and the tube was agitated at ST^C for at least 45 minutes. The 
transformed cells were plated on LB A plates and incubated at 37^C. 
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2.2.7 Screening of positive clone pLDLRP-GCAT-A 
Mini-preparation of plasmid was used to screen positive clones 
carrying the recombinant pLDLRP-GCAT-A recombinant plasmid. A 
single colony was isolated and inoculated in 1.5 mL LBA medium. 
Then the tubes were incubated overnight at 37^C with vigorously 
shaking (200 - 250 rpm). The overnight cultures were spun down in 
microfuge tubes and resuspended in 100 juL PI solution. 200 ^ L of P2 
solution was added and the tubes were put on ice for 5 minutes. Then 
150 |xL 4M sodium acetate (pH 5 - 6) was added and the mixture 
chilled for another 5 minutes. The cell lysate was spun twice for 10 
minutes in a micro-centrifiige and the supernatant was kept at 1 
mL of ice-cold 95% ethanol was added and the DNA was precipitated 
at -20OC for at least 30 minutes. The DNA solutions were spun at 
high speed in the micro-centrifiige for 10 minutes and washed once 
with 70% ethanol. The DNA pellet was dried in vacuum and re-
dissolved in 50 |LIL of TE buffer (pH 8.0). Aliquots of DNA were cut 
with restriction enzymes Bam HI and Sst I. The plasmid DNA was 
separated in a 0.8% TBE agarose gel and after identification of the 
positive clone, a stock of the bacteria in 20% glycerol was made and it 
was stored at -70^C. 
« 
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2.3 DNA sequencing 
The pLDLRP-GCAT-A clone was verified by sequencing with a 
T7 sequencing kit (Pharmacia 27-1682-01) using the LKB 2010 
Macrophor sequencing system. 
2.3.1 Denaturing the double strand template 
The double strand template (2 jug/lOjiiL) was first denatured by 
adding 2 juL 2M sodium hydroxide at room temperature for 10 
minutes. Then the reaction mixture was neutralized by 3 jiiL 3 M 
sodium acetate (pH 4.8)，7 |aL distilled water and precipitated by 
adding 60 |LIL absolute ethanol. The mixture was then placed at -TO^C 
for at least 15 minutes. The precipitated DNA was collected by 
centrifugation for 10 minutes. Next, the DNA pellet was washed with 
ice-cold 70% ethanol and dried under vacuum and finally redissolved in 
10 |j.L distilled water. 
2.3.2 Annealing reaction 
The sequencing primer was adjusted to a concentration equal to 
4.44 |ig/mL as stock. To the above, 10 |LIL denatured template DNA, 
2 \ iL of annealing buffer and 2 juL of primer solution were added. The 
annealing mixture was incubated at 37^C for 10 minutes to anneal the 
primer with template DNA. 
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2.3.3 Labeling reaction 
"Enzyme pre-mix" was prepared by adding 1 |LIL distilled water, 
3 i^L labeling mixed, diluted T7 DNA polymerase (1.5 unit/juL) and 1 
^iL labeled dNTP (1 ^iL = 10 ^iCi) (Amersham SJ 305) for each 
template. The components were mixed by gentle pipetting and the 
contents spun down to the bottom of the tube by a brief centrifugation. 
6 \ iL of "Enzyme pre-mix" was added to the tube containing the 
annealed template and primer. The mixtures were mixed briefly in 
room temperature for 5 minutes. 
2.3.4 Termination reaction 
4.5 juL of the above labeling reaction was pipetted into each of 
the four pre-warmed sequencing mixed (A，G，C and T ,mixed short 
/long). The components were mixed by gentle agitation and incubated 
at 37^C for 5 minutes. 5 juL of stop solution was added to each tube 
and mixed by gentle agitation. The reactions were then heated at 80^C 
for at least 2 minutes and chilled on ice until loading to the sequencing 
gel. 3 |LIL of the sequencing reaction was loaded to appropriate well of 
a denature discontinuous sequencing gel. 
2.3.5 Running and fixing the gel 
The discontinuous denaturing sequencing gel was first pre-run . 
for 30 minutes at 1400 V. After the samples were loaded, the gel was 
electrophoresis for a further 90 minutes. The gel was rinsed with tap 
water and fixed by submerging in a fixing solution (10% acetic acid 
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and 10% methanol) for 30 minutes. The gel was rinsed with tap water 
for 15 minutes and dried at SO^C. An X-ray fi lm (X-OMAT) was 
attached to the dried gel and exposed for two days. Afterwards, the 
f i lm was developed (Kodak 405-1298) and fixed (Kodak 405-1611). 
i 
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2.4 Cell culture and passage of different cell lines. 
Several cell types were used in the study of L D L binding assay 
and they are: Cos 7 (ATCC : CRL 1651，SV40 transformed African 
Green monkey kidney cells), HepG 2 (ATCC : HB 8065，Human 
hepatocellular carcinoma), RTGH-1 (ATCC CCC 82, rat pituitary 
tumour), B M N (from Dr. S. Maeda, University of Califonia, Davis, 
Bombyx Mor i insect cell), Fibroblast (FSF-Human foreskin fibroblast) 
and CHO (ATCC CCL 61，Chinese Hamster Ovary cell line). 
2.4.1 Routine subculture of HepG 2，CHO, FSF，Cos-7 
and FSF 
HepG 2, CHO, FSF and Cos-7 cells were cultured in RPMI 
medium (Gibco 430-1800EL) with 10% fetal calf serum (Gibco) and 
1% antibiotic antimycotic reagent (Penicillin-G streptomycin sulfate-
fungizon (Gibco 600-5240AG). Cells were grown at ？ i n 5 - 6% 
CO2. The split ratio for passage was 1 : 4 and under such conditions, 
cells were subcultured in 4 - 5 days. 
2.4.2 BMN, RTGH-1 
B M N cells were cultured in 2/3 volume of TC 100 medium 
(Invitrogen) and 1/3 volume Grace's medium (Invitrogen) 
supplemented with 10 % fetal calf serum and 1% antibiotic (Gibco). 
The cells were incubated at 27^C. BMN cells were splitted in a ratio 
of 1 : 4 for every 4 - 5 days. 
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RTGH-1 cell was cultured in Minimal Eagle Medium (MEM, 
Gibco) with 15% Horse serum (Gibco 200-6050A J), 2.5% fetal calf 
serum and 1% antibiotic-antimycotic reagent. RTGH-1 cell was 
splitted in a ratio of 1 : 4 every 8 - 1 2 days. 
» 
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2.5 Preparation of human LDL and LPDS 
2.5.1 Purification of LDL 
Human serum pooled from healthy subjects was kindly provided 
by the Chemical Pathology Department in the Prince of Wales 
Hospital. Crude human serum was first centrifuged at 4000 - 5000 
rpm and the supernatant was kept. EDTA was added to a final 
concentration of 0.1 mg/mL and the serum was subjected to 
ultracentrifugation (Beckman L5-50) in 42.1 rotor (Beckman) at 40,000 
rpm, 40c for at least 18 hours. The total volme used in each 
centrifuge tube is about 30 mL. The top 8 mL containing the very low 
density lipoproteins was discarded. 8 mL UF solution (0.196 M NaCl, 
0.003 M EDTA, 0.01 M Tris-HCl and 0.6 M NaBr) was added in 
order to adjust the solution density to 1.063 g/mL. The protein pellet 
was solubilized by gentle stirring with a glass rod. This solution was 
subjected to ultracentrifugation at 40,000 rpm for at least 48 hours at 
40c. 
The top layer containing LDL was aspired and dialyzed against 
PBS (0.016 M Na2HP04, 0.0035 M NaH2P04, 0.03 M NaCl) for 48 
hours at L D L was sterilized by filtration through a 0.45 jiim 
millipore filter. An aliquot of LDL was serially diluted and used for 
Lowry protein determination (Lowry et al，1951). The L D L solution 
was stable at for one month. 
I 
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2.5.2 Purification of LPDS 
Pooled human serum was raised to a background salt density of 
1.21 g/mL by the addition of solid potassium bromide (389.4 mg/mL 
serum). The serum was subjected to ultracentrifugation at 40,000 rpm, 
40c for 36 - 48 hours. The top 12 mL, which contained essentially all 
of the serum lipoproteins was removed. The remaining 12 mL was 
stirred, pooled and dialyzed against PBS for 48 hours at After 
dialysis, the fraction was sterilized by filtration through a 0.45 jum 
Millipore filter. This fraction was designated as lipoprotein deficiency 
serum (LPDS) for cell studies (Gofman et al, 1949; Lindgren, 1975). 
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2.6 DNA transfection and CAT assay 
2.6.1 Transfection of recombinant plasmid to eukaryotic 
cells 
Transcriptional activity of a DNA sequence can be monitored by 
sub-cloning the sequence of interest in front of a reporter gene and thus 
monitoring the level of the reporter gene product. The 
chloramphenicol acetyltransferase (CAT) reporter gene vector pGCAT-
t 
A (Freburg & Brison, 1988) was employed in this thesis. CAT is 
present in prokaryotes only, so the presence of CAT activity in the 
transfected cells should be due to the presence of the transgene. CAT 
catalyses the transfer of acetyl groups from acetyl-coenzyme A (acetyl-
CoA) to chloramphenicol. Acetylation occurs only at the 3'-hydroxy 1 
position. Also, by non-enzymatic rearrangement, 3-acetyI 
chloramphenicol can be converted to 1-acetyl chloramphenicol which 
can further shift the equilibrium of acetylation to the 2-acetyl position 
(Alann & Cook，1990). 
In this study, lipofusion was used for DNA transfection due to its 
effectiveness; 5 - 100 fold higher, when compared to calcium 
phosphate and DEAE-dextran transfection (Feigner et al” 1987). The 
transfection reagent used in lipofusion is lipid vesicles made up of 
cationic amphipiles containing hydrophobic and cationic groups. The 
hydrophobic portion is made up of either cholesteryl or 
dioleoylglyceryl moiety. The cationic portion forms complex with 
DNA by ionic interaction. The DNA-Iipid complex is uptaken by the 
transfected cells through the process of endocytosis. 
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Our transfection procedure was as follows. HepG 2 cells were 
cultivated in 90 mm tissue culture dishes (Comings) until they were 60 
- 8 0 % confluent. 70 |LIL of 1 mg/mL DOTAP transfection-reagent 
(Boehringer Mannherins Biochemica) was mixed with 180 | iL Hepes 
buffered saline (HBS, 20 mM Hepes, 150 mM NaCl, pH 7.4). 5 jiig 
DNA in 250 |LIL HBS was then mixed with the DOTAP solution and 
incubated at room temperature for 10 minutes. The old medium was 
aspirated from the cells and replaced by 13.5 mL culture medium. The 
DOTAP-DNA mix was added to the cells with gentle swirling. The 
final concentration of DOTAP was 5 jug /mL and the cells were 
incubated as described in Section 2.4. 
After 24 hours of incubation, the medium was replaced by fresh 
medium. The cells were further incubated for another 48 hours. 
Normally, during the second 48 hours period, different drugs could be 
added to the culture medium to mediated the control of expression in 
the transfected eukaryotic cell. Cells were harvested at different times 
for determining chloramphenicol acetyltransferase (CAT) activity. 
2.6.2 CAT assay 
參 
The cultured medium was aspirated and cells were washed twice 
with 10 mL PBS. Cells were detached from the dish by incubating 
with 1 mL trypsin solution (0.25% trypsin, 0.2% EDTA in PBS). 
Cells were then washed twice with ice-cold PBS. The pellet was 
resuspened in 1 mL ice-cold PBS and transferred to a microfuge tube. 
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After spinning at 13,000 rpm, the cell pellet was resuspended in 80 | iL 
ice-cold 0.25 M Tris-HCl (pH 7.5) by vortexing. Cells were either 
frozen in liquid nitrogen or continued with the CAT-assay. 
Cells were lysed by 3 cycles of freezing and thawing in liquid 
nitrogen and 37^0. The samples were then sonicated for 10 seconds 
using a microprobe with 50% working cycle. Cell debris was removed 
by centrifugation at 13,000 rpm for 10 minutes. 80 |uL distilled water 
was added to the pellet so as to lyse the cells completely by hypotonic 
shock. The supernatants were pooled and heated at 55^C for 10 
minutes to inactivate endogenous deacetylase which could hydrolyze 
acetyl-CoA and acetyIchloramphenicol. 
After heat inactivation, the samples were cooled on ice and 
denatured proteins were removed by centrifugation at 13,000 rpm for 
10 minutes. A 5 j iL aliquot of the cell extract was used for protein 
determination by Lowry's method (Lowry et al, 1951). The sample 
having the lowest protein content was used as the reference point and 
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2.7 125I.LDL binding assay 
2.7.1 Radioactive iodination of LDL 
L D L was diluted to 1.5 - 3 mg protein/mL with 0.1 M phosphate 
buf fer , p H 7.4 (0.1 M NaH2P04，，0.1 M Na2HP04)， in a borosilicate 
glass test tube (17 X 100 mm) to a volume of 0.5 mL. Iodination was 
started by adding 10 |LI1 of radioactive iodine-125 (1 mCi) (Amersham 
IMS 30) and 50 |LI1 Chloroamine T (4 mg/mL). The mixture was 
vortexed and held on ice. The reaction was stopped exactly in one 
minute by adding 200 jul freshly prepared sodium metabisulfite solution 
(2.4 mg/mL), followed by 100 |i l of potassium iodide (10 mg/mL) 
which acted as a carrier. . 
2.7.2 Purification of iodinated LDL 
By simple gel filtration, a column (1 x 25cm) packed with 
Sephadex G-50 (Pharmacia) was used to separate free and protein 
bound radioactive iodine. The packed column was first equilibrated 
with 0.1 M sodium phosphate buffer (0.1 M NaH2P04，，0.1 M 
Na2HP04 with pH 8.0) The radioactive labeled LDL was eluted as the 
first peak and the free iodine was eluted as the second peak. Aliquots 
of the labeled L D L were diluted for Lowry protein determination and 
gamma counting (Kontron GAMMAmatic II). The specific activity 
(cpm/ng protein) was then determined for subsequent LDL binding 
assay. Labeled LDL can be used for experiment i f stored at for 
‘ n o more than one month. 
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2.7.3 Down regulation of LDL receptor in different 
cell lines. 
The same was used for all the cell types binding assay: 
Confluent cells in 75 cnfi stock flask (Falcon 3024) was either 
trypsinized or scrapped and seeded into the 24 wells plates (Corning 
25820) with a cell concentration of approximately 1 X 10^ cells/mL. 
Cells were incubated as in Section 2.4 until 70% confluent. 
The old medium was aspired and the cells washed twice with 2 
mL PBS (pH 7.4). 1 mL 5% LPDS in RPMI medium (Gibco 430-
1800E) was added to each well. The amount of LDL was adjusted and 
added to each well in order to achieve the different LDL concentrations 
(0，50，100，200 \ig protein/mL). Cells were incubated for further 48 
hours. 
2.7.4 Different Drugs treatment in HepG 2 Cell line 
Chemicals were obtained from Sigma Chemical Co. (St. Louis, 
Mo). HepG 2 cells were prepared as described in Section 2.7.3. The 
old medium was aspired and cells were washed with 2 mL (for 125 j _ 
L D L binding assay in 24 wells plate) or 10 mL (for nuclear protein 
extraction in 100 mm culture disk) PBS. The chemicals used in this 
experiment were 0.1 jug/mL phorbol 12-myristate 13-acetate (PMA), 
10 juM cycloheximide (CHX) and dibutyryl cyclic 3' ,5'-monophosphate 
(dbCAMP), 10 jug/mL monensin and 200 jug/mL 25-
hydroxylcholesterol. 
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The Chinese herb Shanzha was extracted by hot water from the 
fruit Crataegus pinnatifida. The soluble supernatant was then filtered 
by glass filter (Whatman, GF-C), and subjected to freeze drying under 
vacuum. The powder form of crude Shanzha water extract was stored 
dry in - 20^C freezer. The concentration of Shanzha extract used in 
the cell culture was 200 (ag/mL. 
2.7.5 1 2 5 I _ L D L binding assay 
After 48 hours, cells were washed twice with PBS. To each 
well, 1 mL of warm 5% LPDS medium containing 10 jug/mL of ll25一 
L D L was added in the presence or the absence of excess (500 jug/mL) 
unlabeled LDL. Cells were then incubated at 370C for further 3 hours. 
Afterwards, the cells were incubated in a ice bath for 5 - 10 
minutes. The medium was aspired and the cells washed two times with 
1 mL ice-cold Tris-HCl saline (50 mM Tris-HCl, 0.15 M NaCl, pH 
7.4) containing 0.2% BSA and followed by washing with 2 mL Tris-
HCl saline. The cell was lysed by adding 1 mL of 1 M NaOH. The 
cell lysate was used in gamma counting to determine the amount of 125 
I - LDL trapped in the cells. 200 juL of the cell lysate was used to 
determine the content of cellular protein. The amount of radioactivity 
bound per unit cell protien could then be calculated. 
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2.8 Gel-shifted mobility assay 
2.8.1 Extraction of crude nuclear extracts. 
The same procedure was used for all the cell types (Lothan and 
Lubon, 1987). Attached cells were first trypsinized and washed two 
times in 10 pelleted volumes of Dulbecco's phosphate buffer saline 
(Gibco 450-1300) at . Approximately 109 cells were resuspended 
in 5 pelleted volumes of Buffer A (10 mM HEPES-KOH (pH 7.9)，10 
m M KCl, 1.5 mM MgCl�，0.1 mM EDTA, 0.5 mM dithiothreitol 
(DTT)，0.5 mM phenylmethylsulfonyl fluoride (PMSF), 2 |Lig/mL 
Bacitrasin) containing 0.3M sucrose. Cells were lysed by 
homogenization ( 8 - 1 2 strokes) in a glass homogenizer (Wheaton) in 
the presence of 0.3 - 0.4% Nonidet P-40 (Sigma N-6507). The 
homogenate was centrifaged at 11,000 rpm (1200g) (Hitachi RPR 18-3 
rotor) for 10 minutes. The pelleted nuclei were washed twice in Buffer 
A containing 0.3M sucrose. 
Nuclei were resuspended by homogenation (10 strokes) in 2.5 
pelleted volume of Buffer B (10 mM HEPES-KOH (pH 7.9)，400 mM 
NaCl, 1.5 mM MgCl2, 0.1 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF 
and 5% glycerol). The resuspended nuclei were stirred slowly for 30 
minutes at and then subjected to centrifugation for 60 minutes at 
38,000 - 40,000 spun (100,000g) (Beckman 42.1 rotor) at 40C. The 
supernatant was dialyzed for 2 - 4 hours against 50 volumes of Buffer 
C (20 mM HEPES-KOH (pH 7.9), 75 mM NaCl, 0.5 mM EDTA, 0.5 
mM DTT, 0.5 mM PMSF and 20% glycerol) at 40C. Then the extract 
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was cleared by centrifiigation at 17,500 rpm (25，000g) for 15 minutes 
at 40c and was frozen in liquid N2 in small aliquots (10 - 50 juL). 
Samples were stored at -lO^C until use. Aliquots of the extracts were 
taken for protein determination. 
2.8.2 5' end-labeling of synthetic oligonucleotides 
Al l 5' end labelled oligonucleotides used in this thesis would 
follow the same procedures as described below. 16 bp a树/-sense 
Repeat 2 (5' GCAGT GGGGG TGATT T 3') and sense Repeat 2 (5' 
A A A A T CACCC CACTG C 3') oligonucleotides of human low 
density lipoprotein receptor promoter (see Appendix 1) were 
synthesized and purified as mentioned in Section 2.1 and 1 jug of these 
oligonucleotides (SjuL) was added to a 1.5 mL eppendorf tube along 
with 2.5 \ iL of 10 X kinase buffer, 2 | iL (6 units) of polynucleotide 
kinase, 5.5 juL of autoclaved double distilled water and 16 juL of Y-p32 
-dATP (Amershem PB. 10168). The mixture was vortexed and spun 
down in a microfuge and the labeling reaction allowed to proceed at 
370c for 45 - 60 minutes. 
2.8.3 Purification of labeled oligonucleotides 
In order to separate the free y-p32_dATP from labeled 
oligonucleotides, PUSH Column (Stratagene 400701) was used. 45 juL 
of STE (20 mM Tris-HCl, 100 mM NaCl, 10 mM EDTA) was added 
to the labeling mixture. The PUSH Column was first pre-wet with 70 
|LIL of STE. The diluted labeled mixture was applied to the PUSH 
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Column. By applying force to the 10 mL plastic syringe connected to 
the top of the PUSH Column, the labelled oligonucleotide was eluted. 
The column was then rinsed once with 70 jiiL STE and all eluents were 
pooled. 1 - 2 j iL of the eluent was diluted and counted in a liquid 
scintillation (Beckman LS-1801) to determine its radioactivity. 
2.8.4 Nuclear protein and DNA binding reaction 
Labelled Repeat 2 duplex was first annealed by boiling the same 
amount of sense (Ijug/jiL) and anti-sense (Ijng/juL) oligonucleotides to 
90OC and cooled down slowly in water. 1 jug of nuclear protein extract 
was added along with 1 jug poly(dl-dC) in 25 juL of Buffer D (10 mM 
Tris-HCl (pH 7.5)，75 mM KCl, 1 mM EDTA，5 mM MgCl2, 1 mM 
DTT, 12.5% glycerol, 0.1% Triton X-100) in a microfuge tube and 
incubated for 20 minutes at room temperature. Then 1 ng of the 
labelled Repeat 2 duplex was added and incubated for an additional 40 
minutes. 
2.8.5 Gel-shift mobility electrophoresis by 
PhastSystem 
Gel-shift was performed in a PhastSystem '^^  (Pharmacia -18-
1600-01) using PhastGel Homogeneous 20 (Pharmica 17-0624) gel 
strips and PhastGel Native Buffer Strip (Pharmacia 17-0517). 25juL of 
the binding reaction mixture was mixed with 5X loading buffer (250 
mM Tris-HCl (pH 8.0), 50% glycerol, 0.25% Sodium azide, 0.25 
mg/mL Bromophenol blue) and 4 |xL of it applied to the gel. The 
condition of separation was 400 V，10.0 mA at using the following 
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separation program: SAMPLEAPPL. DOWN AT 1.2 OVh; 
SAMPLEAPPL. UP AT 1.2 2Vh; SEP 1.1，400V, 10.0 mA, 2.5W, 
40c lOVh; SEP 1.2, 400V 1.0 mA 2.5W 40C 2Vh; SEP 1.3 400V, 
10.0 mA, 2.5W, 268Vh and end at SEP 1.4，lOOV, 1.0 mA OVh. 
Following electrophoresis, the gels were autoradiographed overnight at 
-70OC using an intensifying screen. 
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2.9 Construction of 入 gt 11 cDNA library of HepG 2 cell 
2.9.1 Purification of mRNA from HepG 2 
QuickPrep丁M Micro mRNA Purification Kit (Pharmacia 27-9255-
01) was employed in preparing HepG 2 cell mRNA. The procedure 
used was exactly the same as the Kit's manual (see appendix 4). 
2.9.2 cDNA preparation 
TimeSavefTM cDNA Synthesis Kit (Pharmacia 27-9262-01) was 
employed for preparation of cDNA library of HepG 2 cell. The 
procedure used was exactly the same as the Kit's manual (see Appendix 
5). 
2.9.3. In-vitro packaging of phage 
The column effluent from the cDNA reaction mixture was mixed 
with 7 A. gt 11 arms and coprecipitated by the addition of 3M 
sodium acetate and cold ethanol. The mixture was precipitated at -
TO^C for 15 minutes. The DNA pellet was obtained by centrifugation 
for 10 minutes in a microfuge. The supernatant was removed and the 
pellet was dried under suction. Then the pellet was redissolved in 
ligation buffer and 1 [ iL ATP and 1 jiiL of T4 DNA Ligase were then 
added. The reaction mixture was incubated at 160C for 30 minutes. 
The packaging extract was thawed on ice. The ligated reaction 
mix containing X gt 11 cDNA was then added. The mixture was 
48 
‘ Materials and Methods. 
swirled gently to avoid introducing bubbles and the tube was incubated 
at room temperature for an hour. 0.5 mL of SM buffer and a drop of 
chloroform was added and debris was removed by centrifugation for 
thirty seconds at room temperature. 
2.9.3 Screening the expression library 
The HepG 2 cDNA library was plated on 90 mm plates 
containing a maximum of 2 X 104 pfu per plate in 0.5 % top agar. An 
IPTG (1 mM) saturated nitrocellulose filter was overlaid on the top the 
culture and the whole setup was incubated at 370C for 5 - 6 hours. 
Afterwards, the plates were cooled at for 10 minutes and the 
positions of the filters were marked. Filters were lifted and put 
immediately into a BLOTTO solution (5% Carnation nonfat milk 
power, 50 mM Tris (pH 7.5)，50 mM NaCl, 1 mM EDTA, and 1 mM 
DTT). In all subsequent steps, filters were incubated with the protein 
surface up and were transferred from one solution to another quickly to 
prevent drying. Filters were incubated in BLOTTO overnight with 
gentle shaking then washed two times with TNE-50 (10 mM Tris (pH 
7.5)，50 mM NaCl, 1 mM EDTA and 1 mM DTT). For screening, the 
filters were incubated in aliquots of TNE-50 containing 32p labeled 
oligonucleotides (1 - 2 X 10^ cpm/mL) and calf thymus DNA (10 ju 
g/mL). After overnight incubation at with gentle agitation, the 
filters were washed four times (a total of 30 minutes) with TNE-50. 
Filters were patted dry and exposed to Kodak X-OmatAR film with an 





3.1 Construction of recombinant plasmid 
3.1.1 hLDLR-promoter X 34 clone 
The freeze-dried phage lysate hLDLR-promoter X 34 clone used 
in this thesis was brought from American Type Culture Collection 
(57246). The hLDLR-promoter was inserted in the charon 4A vector 
EcoR I site. In order to obtain a large amount of hLDLR-promoter 
DNA, the phage lysate was rehydrated by SM buffer and infected thr 
host bacteria Y 1090. Five confluent lysis were prepared and the 
hLDLR-promoter DNA was extracted. The amount of DNA was 
quantified by cutting with EcoR I restriction enzyme and running in a 
0.8% agarose gel. As depicted in Figure 3.1, the EcoR I digested 
hLDLR-promoter clone gave (Lane 2) five distant bands in 0.8% TBE 
buffered agarose gel when compared to the uncut control (Lane 3). 
Using X Hind I I I marker as reference, the bands obtained were 
approximately 19，10，9，2 and 1 kilo base pair long. This pattern 

















Agarose gel electrophoresis of hLDLR-入 34 clone DNA. Lane 1:入 
Hind I I I DNA marker; Lane 2: EcoR I restriction digested 
hLDLR-入 34 DNA; Lane 3: uncut control of hLDLR-入 34 DNA. 
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3.1.2 Restriction site generation in LDLR-promoter by 
PGR 
The purified hLDLR-promoter X DNA clone was subjected to 
PCR using Primer 624A and Primer 58B (Figure 3.2). In order to 
subclone the LDLR-promoter fragment into the pGCAT-A reporter 
plasmid, two unique restriction sites {BamH I and Sac I), were 
introduced during the PCR. Primer 624A was a 35-base 
oligonucleotide which has a 25 bases pair (- 624 to - 599) match with 
that of the hLDLR-promoter. At the 5' end, a BamH I restriction site 
and a dT cramp site was introduced. Primer 58B is a 37-base 
oligonucleotide which has 27 bases pair (- 58 to - 75) matching those of 
the hLDLR-promoter. A Sac I site and a dC cramp site was located at 
51-end. The amplified fragment included the 3 imperfect direct 
repeats, the 2 TATA box-like sequence (- 58 to - 624) and the whole 
sterol-responsive element (Siidhof et al, 1987a). 
The amplified hLDLR-promoter (-58 to -624) was separated 
f tom other side products in 0.8% TBE buffered agarose gel (Figure 
3.3). A distint single band was observed at the 0.56 kb position (Lane 
2 and 3). The size of the PCR product matched that of the calculated 
size of the LDLR-promoter sequence (Appendix 1). This PCR product 
was excised from the agarose gel and purified by the Gene Clean kit 
(Bio 101) (Lane 5).The presence of the BamH I and Sac I restriction 
sites were verified and tested by cutting the PCR product with the two 
enzymes. After double enzyme digestion, the PCR product was self-
ligated by T4 DNA ligase (NewEngland BioLab.). A 0.56 kb DNA 
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Name of primers Sequence of primers 
Primer 624A 5' - TTTTT GGATC CTGAT TGATC 
AGTGT CTATT AGGTG 3' 
Primer 58B 5' CCCCC GAGCT CTGGA A A C r r 
TGGCT TCCCG CGATT GC 3' 
Repeat 2 sense strand 5' - AAA ATC ACC CCA CTG C - 3'~~ 
(R2S): 
Repeat 2 antisense strand 5' - GCA GTG GGG TGA TTT T - 3' 
(R2A): 
Mutated Repeat 2 5' - AAA ATC ACC TAT GCG C - 3' 
sense strand(MR2S): 
Mutated Repeat 2 5丨-GCG CAT AGG TGA TTT T - 3' 
antisense strand(MR2A): 
EPO sense strand 5' - ATC ACT GTC CCA GAC ACC-3' 
EPO antisense strand 5丨-GGT GTC TGG GAC AGT G - 3' 
Figure 3.2 
The primers used in this thesis is shown above. The underlined 
sequence are restriction sites in-corporated. 
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Figure 3.3 
Agarose gel electrophoresis of PCR product of human LDLR-promoter 
by using primer 624A and 58B. Lane 1: negative control; Lane 2 
and 3: PCR product of uncut clone and EcoR I restriction 
digested clone; Lane 4,6 and 7: X Hind I I I digested marker; Lane 
5: Gene Clean product of lane 3; Lane 8: Self-ligation of BamHI 




ladder as shown in Lane 8 (Figure 3.3) illustrated that the two 
restriction sites were created successfully. 
3.1.3 Preparation of pGCAT-A reporter plasmid 
The reporter plasmid pGCAT-A (see Appendix 2) was purified 
by Qiagen tip-100 (Qiagen). The amount of DNA obtained was then 
estimated by agarose gel electrophoresis (Figure 3.4，Lane 2). The 
purified reporter plasmid pGCAT-A was subjected to BamHI and Sac I 
digestion. Finally, the digested pGCAT-A was cleaned by Gene Clean 
kit (Bio 101). 
3.1.4 Screening of pLDLRP-GCAT-A recombinant 
Approximately 100 ng enzyme-digested LDLR-promoter insert 
and 50 ng enzyme-digested reporter plasmid pGCAT-A were ligated by 
T4 D N A ligase (New England BioLab.). Figure 3.4 depicted the result 
of a mini-preparation of a recombinant plasmid. A 0.56 kb DNA 
fragment was generated after double digestion with BamH I and Sac I . 
The positive clone (Lane 3 and 6) was isolated and stored at -TO^C. 
Lane 4 and 5 show a control in which no DNA were inserted in the 
pGCAT-A reporter plasmid. 
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Agarose gel electrophoresis in screening a positive pLDLRP-GCAT-A 
clone. Lane 1:入 Hind I I I digested marker; Lane 2: Sst I (Sac I 
isoschizomer) restriction digested pGCAT-A reporter plasmid; 
Lane 3 to 6: plasmid digested with BamH I and Sst I. Lane 3 and 
6 showed that LDLR-promoter were inserted to the BamH I and 
Sst I restriction sites; Lane 4 and 5 showed that no DNA fragment 
was inserted in the control plasmid after the double digestion with 
BamH I and Sst restriction enzymes. 
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3.1.5 Sequencing of pGCAT-A-LDLR-promoter 
recombinant 
Figure 3.5 shows the autoradiograph of sequencing data in both 
strands of the pLDLRP-GCAT-A reporter plasmid. No base mutation 
by PCR was observed when compared with the published sequence 
(Siidhof et al, 1985a) (see Appendix 1). 
3.2 CAT assay of recombinant plasmid on transfected 
HepG 2 cell 
CAT enzyme was extracted from HepG 2 cells treated under 
various conditions. As depicted in Figure 3.6，the CAT enzyme could 
be expressed successfully in the pGCAT-A-LDLR-promoter construct. 
However, no significant suppression of CAT activity was observed 
when the transfected cells were treated in the presence and absence of 
L D L or 25-hydroxylcholesterol. 
3.3 125 I - LDL binding assay 
3.3.1 125 I - LDL binding assay of different cell lines 
The expression of LDLR, in vivo, can be inhibited by the 
presence of excess LDL. Therefore the number of LDLR on the cell 
surface can be suppressed by adding different amount of L D L in cell 
culture medium. Figure 3.7 shows the L D L induced down regulation 
of LDLR in different cell lines. The lack of a response in 
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Figure 3.5. 
Autoradiograph of DNA sequencing of LDL receptor promoter by 
dideoxy chain-termination method. Lane 1 and 2: sequence of 
sense strand of LDLR-promoter between -346 to -518 and -518 to 
-597 respectively; Lane 3 and 4: sequence of anti-sense strand of 
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CAT assay of HepG 2 lysate, different drugs treatment after 
transfection of pLDLRP-GCAT-A. Lane 1: HepG 2 cells 
transfected with CAT 2 recombinant plasmid; Lane 11: CAT 
enzyme positive control; Lane 2: HepG 2 cells transfected with 
negative control CAT 3 recombinant plasmid; Lane 3 and 4: 
HepG 2 cells incubated with plain RPMI medium for 48 hours; 
Lane 5 and 6: HepG 2 cells incubated in LPDS medium for 48 
hours; Lane 7 and 8 : HepG 2 cells grown in LPDS medium 
supplemented with 200 jug/mL LDL; Lane 9 and 10: HepG 2 
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Figure 3.7 
Al l cell types were cultured in LPDS medium in 24 wells plate at 
in a 6% CO2 incubator. Different concentrations of LDL (0，50， 
100 and 200 jug/mL) were added and incubated for further 48 
hours. Then, cells were harvested for 125 l -LDL binding assay. 
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the BMN, RTGH-1 and Cos 7 cell lines indicates that there are 
unlikely any LDLR in the surface of these cells. On the other hand, 
the HepG 2，FSF and CHO cell lines bear LDLR on their cell surfaces 
and all of them can be down regulated in the presence of L D L in a dose 
response manner. Compared with CHO and HepG 2 ceils, the 
response from FSF cells was much more pronounced. 
3.3.2 Characterization of cell surface receptor of HepG 2 
cell by different drugs treatment. 
HepG 2 cells were selected for further studies in the investigation 
of specific nuclear protein which can bind onto the Repeat 2 
oligonucleotides because it is a well-established, characeterized, 
immortal cell line and can provide us with a consistent and limitless 
supply of material to work with. As depicted in Figure 3.8，the 
presence of 200 jug/mL L D L can reduce the expression of LDLR 
(Lane 3) when compared with the control (Lane 1). The addition of 
Shanzha (SC) to the LPDS control did not induce any significantly 
overexpression of LDLR (Lane 2), but the addition of Shanzha in the 
presence of L D L (Lane 4) greatly enhanced LDLR when compare with 
either the LPDS control (Lane 1) or the LPDS + L D L treatment (Lane 
3). In the presence of 25-hydroxylcholesterol (25HCS), the expression 
of L D L R was retarded (Lane 5 vs Lane 1). The presence of Shanzha 
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Figure 3.8 
HepG 2 cells were cultured in LPDS medium with various treatments 
at 370c，6% CO2 for 48 hours. The concentrations of LDL used 
was 200 jiig/mL and that for 25-hydroxylcholesterol was 
equivalent to the same amount of cholesterol from 200 jiig/mL 
LDL. The concentration of SC was also 200 |ig/mL. 
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3.4 Gel shifted mobility assay 
3.4.1 Binding effect of Repeat 2 to different cell lines 
The specific binding of nuclear protein extracted from different 
cell lines to Repeat 2 was evaluated by gel-shift analysis and the results 
are shown in Figure 3.9. Lane 1 to 6 showed non-specific binding 
while lane 7 to 12 showed specific binding. The nuclear extract from 
B M N cell (Lane 12) showed no significant binding with Repeat 2 while 
those from HepG 2 (Lane 1 and 8)，CHO (Lane 2 and 9)，FSF (Lane 3 
and 10) and Cos 7 (Lane 4 and 11) cell lines appeared to contain 
proteins which can bind to this sterol responsive element. 
3.4.2 Optimizing the binding reaction in HepG 2 cell by 
poly(dLdC) 
In order to assess the specificity of nuclear proteins in the binding 
of Repeat 2，one jiig of nuclear protein was incubated with different 
concentrations of poly(dLdC). Preincubation of nuclear protein with 
poly(dl.dC) before adding the labelled probe prevented the buildup of 
nonspecific DNA-protein complexes which can mimic the effect of 
specific DNA binding and show a dark band in the film. The nuclear 
extract from HepG 2 cells was incubated with one nanogram of labelled 
Repeat 2 in the presence of different concentrations of poly(dl.dC) and 
gel-shift analysis was then performed so as to optimize the amount of 
poly(dLdC) to be added. As indicated in Figure 3.10，one of the bands 
that bound to Repeat 2 could be displaced by the poly(dl.dC), while 











Autoradiograph of Phastgel native band-shift electrophoresis showing 
the binding character of nuclear protein to radioactive end-labeled 
Repeat 2 in different cell lines. Lane 6 and 7 were the radioactive 
labelled Repeat 2 probe; Lane 1 and 8 were the HepG 2 cell line; 
Lane 2 and 9 were the CHO cell line; Lane 3 and 10 were the Cos 
7 cell line; Lane 4 and 11 were the FSF cell line; Lane 5 and 12 
were the BMN cell line. Lane 7 to 12 were the routine binding 
reaction with 1 |Lig competitive DNA poly(dLdC). Lane 1 to 6 















Optimization of poly(dLdC) concentration in gel-shift assay. Lane 1 to 
6 contained 1 ng labelled Repeat 2 probe in binding buffer; Lane 2 
to 5 contained 1 jug HepG 2 nuclear protein; Lane 3 was 
supplemented with 1 |xg poly(dLdC); Lane 4 was supplemented 




3.4.3 Specificity of Repeat 2 in binding to HepG 2 cell 
nuclear protein 
It is necessary to demonstrate the specificity of binding in order 
to confirm that the interaction between the nuclear protein and the 
D N A fragment of interest is specific. This can be done in a 
competition assay using a defined amount of poly(dl.dC) and increasing 
concentrations of unlabeled competitor DNA. In the presence of 
saturating non-specific DNA, such as poly(dl.dC)，only the specific 
D N A binding protein can bind onto the region of interested. On the 
other hand, in the absence of non-specific DNA, non-specific DNA 
binding proteins wi l l bind onto the region of interest also. 
In this study, the specificity of HepG 2 nuclear protein to bind 
Repeat 2 is shown on Figure 3.11. Fifty fold excess of unlabeled 
Repeat 2 was able to displace all the radioactive Repeat 2 bound on the 
nuclear extract producing a clear region in the band where the protein 
D N A complex was formed (Lane 3 vs Lane 2). On the other hand, the 
specific band between Repeat 2 and the nuclear protein cannot be 
displaced by a 100 fold excess of MR2 and a randomly selected 17 
bases pair EPO duplex (Lane 4 and 5). In view of these results, the 
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Figure 3.11 
Autoradiograph of Phastgel native electrophoresis showing specificity 
of the shifted band. HepG 2 cells were cultured in LPDS medium 
with the addition of various concentrations of LDL for 48 hours. 
Lane 1 to 6 contained 1 ng labelled Repeat 2 probe; Lane 1 to 5 
also contained 1 jug nuclear protein. Lane 2 to 5 contained Ijiig 
poly(dl.dC); Lane 3 supplemented with 50 ng unlabeled Repeat 2 
probe (50 fold excess); Lane 4 supplemented with 1 jiig of 
scramble mutated Repeat 2 (MR2) oligonucleotide (100 fold 
excess); Lane 5 supplemented with 1 jug of random selected 17 
base pair oligonucleotides (100 fold excess). 
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3.4.4 LDL dose response treatment in HepG 2 cell 
3.4.4.1 Binding of Repeat 2 to specific nuclear protein 
I 
Since L D L is known to down regulate its own receptor at a dose 
dependent manner, we are interested to ascertain i f a similar response 
may occur in the nuclear protein which binds specifically to Repeat 2. 
The result of such an experiment is described in Figure 3.12. As 
indicated, no significant difference in the amount of DNA-protein 
complex could be observed when HepG 2 cells were treated with 
increasing concentrations of LDL. The intensity of the band formed 
between Repeat 2 and the nuclear protein remained rather constant 
when cells were grown in the presence of 0，50，100 or 200 jtig/mL 
LDL . 
3.4.4.2 Binding of Repeat 2 to a non-specific cell 
nuclear protein from cells treated with LDL 
From our previous studies, the expression of specific Repeat 2 
nuclear binding protein (R2-BF) showed no significant difference in 
L D L dose response treatment. This implies that the expression of R2-
BF was not triggered by LDL. In order to investigate a nuclear protein 
which is dose responding with the LDL, gel-shift assay was performed 
without the addition of poly(dl.dC) so that the dark bands of all non-
specific DNA binding protein wi l l be shown in X-ray film. As 
depicted in Figure 3.13, a DNA nuclear binding protein can be totally 
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Autoradiograph of Phastgel native band-shift electrophoresis showing 
the effect of different concentrations of LDL on the production of 
specific binding protein in HepG 2 cells. HepG 2 cells were 
cultured in LPDS medium with the addition of various 
« 
concentraions of LDL at 370C in 6% CO2 incubator for 48 hours. 
Lane 1 to 6 contained 1 ng labelled Repeat 2 probe; Lane 2 to 6 
contained 1 \xg nuclear protein extract from HepG 2 cells; Lane 3 
nuclear protein was extracted from 0 jug/mL LDL treatment; Lane 
4 nuclear protein was extracted from 50 jug/mL LDL treatment; 
Lane 5 nuclear protein was extracted from 100 |Lig/mL LDL 
treatment; Lane 6 nuclear protein was extracted from 200 |Lig/mL 
L D L treatment. Lane 3 to 6 were supplemented with 1 jug 
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Figure 3.13 
Autoradiograph of Phastgel native band-shift electrophoresis showing 
the effect of different concentrations of LDL on the production of 
non-specific binding protein in HepG 2 cells. Lane 1 to 6 
contained 1 jug nuclear protein, 1 ng labelled Repeat 2 probe and 
gel-shift binding buffer. Lane 1 and 2 nuclear protein were 
extracted from 200 jug/mL LDL treatment (48 hours); Lane 3 and 
4 nuclear protein were extracted from 50 |ig/mL LDL treatment 
(48 hours); Lane 5 and 6 nuclear protein were extracted from cells 
not treated with LDL (48 hours). Lane 1, 3 and 5 were assayed 
with 1 |ig poly(dLdC) to show specific binding while lane 2，4 and 
6 were assayed without poly(dl.dC) to show non-specific binding. 
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displaced by adding one microgram of poly(dLdC) DNA (Lane 1，3 
and 5 vs Lane 2, 4 and 6). Also, the expression of one of this non-
specific DNA binding protein is enhanced, when HepG 2 cell was 
incubated with 200 |ig/mL L D L (Lane 2)，when compare with the 
control treatment (Lane 4 and 6). Thus, L D L can induce the 
expression of a non-specific DNA binding protein but not the one for 
Repeat. 
3.4.5 Effect of different drugs on the binding of Repeat 2 
to nuclear proteins in HepG 2 cell 
In order to determine the mechanism on the regulation of the 
transcription factor interacting with Repeat 2，drugs which are known 
to have effects on protein synthesis and signal transduction were used 
to ascertain i f such pathways were involved. When cells were treated 
with phorbol 12-myristate 13-acetate (PMA) for 30 minutes (see Figure 
3.14，Lane 6) and 3 hours (Lane 5), a significant suppression in the 
binding of Repeat 2 was observed at the 3 hour point. With the 
cycloheximide (CHX) (Lane 4) and monensin (Lane 3) a similar 
suppression of binding was also observed. In contrast, treatment with 
dibutyryl-cyclic - AMP (dbCAMP) (Lane 2) produced no significant 
changes in the level of binding when compared with the control (Lane 
1). 
For the non-specific nuclear protein, only CHX (Lane 10) and 












Autoradiograph of Phastgel native band-shift electrophoresis showing 
the effect of different protein inhibitors on the binding of nuclear 
protein to Repeat 2 in HepG 2 cell line. HepG 2 cells were 
incubated in the standard conditions with the addition of various 
types of drugs. Lane 6 and 12: PMA treatment for 30 minutes; 
Lane 5 and 11: PMA treatment for 3 hours; Lane 4 and 10: CHX 
treatment for 48 hours; Lane 3 and 9: monensin treatment for 48 
hours; Lane 2 and 8: dbCAMP treatment for 48 hours; Lane 1 and 
7: normal serum treatment. Lane 1 - 6 were the routine binding 




binding for Repeat 2 by one half. Other drugs could only exert little or 
no significant effect on this non-specific nuclear protein. 
From our data presented in Figure 3.8，Shanzha has the unique 
property in preventing the down regulation of the L D L receptor in 
HepG 2 cells by LDL . To assess whether this action may be due to the 
effect of Shanzha in preventing the interaction of Repeat 2 with a 
potential regulatory nuclear protein, the influence of this compound in 
the binding of Repeat 2 was evaluated. As depicted in Figure 3.15， 
treatment with Shanzha (Lane 3,4,7,8,11 and 12) greatly suppressed 
the specific and non-specific nuclear protein that bind onto Repeat 2 
irrespective of whether L D L or 25-hydroxylcholesterol were present. 
As observed before, excess L D L in the culture medium can induce the 
production of a non-specific nuclear protein in HepG 2 cell (Lane 5 and 
6 vs Lane 1 and 2). Although 25-hydroxylcholesterol treatment is 
known to mimic the condition of L D L treatment, in this case, no 
increase of the non-specific nuclear protein was observed (Lane 9 and 
10) while the level of the specific nuclear protein remained unaffected. 
3.5 HepG 2 cell cDNA library screening 
In order to use a radioactivly labeled Repeat 2 as a probe to screen 
a cDNA expression library for nuclear proteins which may act as sterol 
responsive factor, we first evaluate i f a radioactively labeled Repeat 2 
can bind specifically to the nuclear extract spotted into nitrocellulose. 
The nuclear extract from HepG 2 cells was serially diluted and dotted 
onto a nitrocellulose paper. The paper was then 
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1 2 3 4 5 6 7 8 9 10 11 12 
Figure 3.15 
Autoradiograph of Phast native band-shift electrophoresis showing the 
effect of Shanzha treatment on the binding of nuclear protein to 
Repeat 2 in HepG 2 cell line. Lane 1 and 2: the cells were 
cultured in LPDS medium; Lane 3 and 4: the cells were cultured 
in LPDS supplemented with 200 |Lig/mL Shanzha; Lane 5 and 6: 
the cells cultured in LPDS supplemented with 200 jug/mL LDL; 
Lane 7 and 8: the cells cultured in LPDS supplemented with 200 JLI 
g/mL L D L and 200 jug/mL Shanzha; Lane 9 and 10: the cells 
cultured in LPDS supplemented with 200 |ag/mL 25-
hydroxylcholesterol ； Lane 11 and 12: the cells cultured in LPDS 
with the supplement of 200 jug/mL 25-hydroxylcholesterol and 




incubated with labeled Repeat 2. After washing , positive signals could 
be observed in areas at which 6 jug (Lane 1) and 3 |Lig (Lane 2) of 
nuclear proteins were applied (see Figure 3.16). And after screening 
for twenty plates, no positive clone could be identified. 
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Figure 3.16 
Autoradiograph showing a positive control in screening of the HepG 2 
cell cDNA library by labeled Repeat 2. Lane 1: 6 |ig of nuclear 






4.1 Strategy on construction of reporter plasmid 
pLDLRP-GCAT-A 
Polymerase Chain Reaction (PCR) has become the most 
commonly used method in molecular cloning because of its simplicity 
and ease of operation. In the construction of pLDLRP-GCAT-A, PCR 
was employed instead of using conventional cloning procedures. 
The LDLR-promoter consists of a 0.68 kb fragment located at 
the 5'-flanking region of the LDLR gene (see Appendix 1). The 
restriction sites residing in the LDLR-promoter were searched by 
computer, using the program DNasis version 7.0. There is no suitable 
restriction site that flanks the LDLR-promoter and in order to sub-
clone the LDLR-promoter into a CAT reporter plasmid vector 
(Frebourg and Brison, 1988)，two unique restriction sites, BamH I and 
Sac I, were designed into the PCR primers for subsequent insertion of 
the promoter into the CAT plasmid. These restriction sites chosen are 
located in the multiple cloning site in the pGCAT-A reporter plasmid 
vector. In order to obtain a specific annealation of primers to the 
LDLR-promoter, as shown in Figure 3.2, the primers 624A and 58B 
have 25 and 27 bases matched with the sequence of LDLR-promoter at 
-624 and -58 regions, respectively. Besides the addition of restriction 
site, 5 bases of T or C were synthesized at the 5'-end region of both 
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primers, so as to provide a place for the corresponding restriction 
enzyme to cramp on it during the enzymatic reaction. 
4.2 The expression of CAT in HepG 2 cell 
The ability to examine the transcriptional activity of cloned 
genomic sequences after introduction of these elements into appropriate 
cells has substantially enriched our understanding on the regulation of 
mammalian gene transcription. These studies have been greatly 
simplified by the development of reporter gene vectors. 
Reporter genes code for proteins that possess a unique enzymatic 
activity or are otherwise easily distinguishable from the mixture of 
intra- or extracellular proteins. The basic strategy for analyzing the 
transcriptional properties of DNA elements using reporter gene is as 
follows. In order to test for the fiinctional promoter elements, the test 
DNA was ligated upstream of the coding region of the reporter gene to 
generate a chimeric gene in which the putative regulatory element 
controls the expression of the reporter gene. Subsequently, these 
fusion genes are introduced into cultured cells or into animals. Then 
the transcriptional capability of the test DNA was then estimated 
quantitatively from the in vitro activity of the reporter gene product in 
the culture medium or in cellular or tissue derived extracts or was 
determined by histochemical staining of intact cells. Generally, the 
reporter gene activity is directly proportional to transcriptional activity. 
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Transfection is a word describing the techniques in the 
introduction of DNA into cells. The common popular techniques used 
in transfection, nowadays, are the use of calcium phosphate, DEAE-
dextran, lipofection and electroporation. The first three methods 
enhance DNA interactions with the cell surface and, therefore, promote 
DNA uptake by endocytosis; whilst electroporation relies on 
electrically introducing pores on the cell membrane through which 
DNA passively enters. 
Lipofection was employed as a transfection tool in this thesis. It 
is because the lipofection technique is an efficient way in the active 
uptake process of introducing DNA into cells. Depending on the cell 
line, lipofection is 5 to > 100-fold more effective than' either calcium 
phosphate or the DEAE-dextran transfection technique (Feigner et al 
1987). 
The results of the CAT assay from HepG 2 cells transfected with 
pLDLRP-GCAT-A is presented in Figure 3.6. It is evident that these 
cells could express the CAT gene but not in a sterol responsive 
manner. It was expected that when these cells were incubated in the 
presence of LDL, the expression of the CAT enzyme could be 
suppressed while in the absence, the expression of the CAT enzyme 
would be overexpressed. However, our result showed no significant 
difference in the expression of the CAT enzyme when the transfected 
cells were treated with and without LDL. 
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Using the CAT assay to quantify the function of a promoter has 
several drawbacks. Firstly, the CAT enzyme may be inactivated or 
denatured during the extraction process. And the different degree of 
denaturation or inactivation in different samples may cause additional 
error when comparing results quantitatively. Secondly, the LDLR-
promoter in HepG 2 cells may compete with that of the pLDLRP-
GCAT-A construct so the effect of down regulation may be hindered 
and the CAT assay may not differentiate the slight changes of 
expression of CAT enzyme in various LDL treatments. Because of 
these drawbacks, the CAT system may merely identify the interested 
upstream promoter in either turning on or off the CAT reporter gene. 
4.3 Identification of a DNA binding protein for Repeat 2 
in HepG 2 cell 
The LDLR-promoter Repeat 2 was hypothesized to be the key 
region involved in the down regulation of LDLR by sterol and LDL. 
(Dawson et al, 1988). A specific-DNA binding protein has also been 
identified recently in CHO cell which could bind to Repeat 2 (Stark, 
1992). In order to regulate gene expression, DNA-binding proteins are 
often involved and play a crucial role. 
In our study, a cell line had to be selected to develop a model on 
LDLR regulation at the gene level. Such a cell line should have LDLR 
on its cell surface. 125 I -LDL binding and gel-shifted assay were 
performed in six different types of cells so as to characterize their 
ability to bind of LDL. 
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As depicted in Figure 3.7，HepG 2，CHO and FSF cells were all 
effective in the binding of 125 I -LDL while the BMN, RTGH-1 and 
Cos 7 cells show no such effect. Moreover, the former cell lines all 
showed a L D L dose response down regulation of LDLR. 
The results of gel-shifted assay are shown on Figure 3.9. B M N 
cells show no shifted band and this implies that no specific nuclear 
protein exists in this cell line for Repeat 2 to bind. This is reasonable 
since insect cell does not bear LDLR. In HepG 2，CHO, FSF and Cos 
7 cells a band shift was observed indicating that the nuclear proteins in 
these cells can bind to Repeat 2. Contrary to our notion that LDLR 
and the regulation protein for Repeat 2 have to coexist in the same 
cells, Cos 7 cell were shown to contain no LDLR and yet it has the 
nuclear proteins which binds to Repeat 2. This anomaly may be 
accountable by the fact that any sterol regulatory proteins that bind on 
to Repeat 2 may not be directly involved in L D L metabolism. 
According to data obtained from 125 I -LDL binding and gel-
shifted assay, HepG 2 cells were chosen in developing the model for 
L D L R regulation at the gene level instead of FSF cell line. The merits 
of using HepG 2 cells are: HepG 2 cells are well established and 
characterized, it bears LDLR and. its LDLR level can be down 
regulated by addition of LDL, its physiology resembles the liver and 
because it is a cell line it can propagate indefinitely., 
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4.3.1 Binding effect of nuclear protein to Repeat 2 
4.3.1.1 LDL dose response relationships 
After the characterization of the specific DNA binding protein 
for Repeat 2 (tentatively abbreviated as R2-BF), its role in regulating 
the expression of LDLR was studied. Since L D L can induce the 
suppression of LDLR, this lipoprotein may trigger a series of reactions 
resulting in the down regulation of its receptor. To evaluate this 
phenomenon, HepG 2 cells were exposed to different levels of LDL 
and their nuclear proteins were extracted to determine i f there is a 
relationship between the level of R2-BF and receptor down regulation. 
The results are shown in Figure 3.12, the amount of R2-BF in HepG 2 
cell, however, showed no significant change in the L D L dose response 
treatment. This implies that LDL cannot activate or suppress the 
expression of R2-BF. 
On the other hand, the LDL dose response treatment was shown 
in our study to induce the expression of a non-specific DNA binding 
protein in HepG 2 cells (Figure 3.13). The level of expression of the 
non-specific DNA binding protein, in the presence of 200 |Lig/mL LDL, 
is higher while the control, cells incubated in LPDS, showed little 
expression. This indicates that LDL can somehow activate the 




4.3.1.2 Effect of protein inhibitors 
Cells usually maintain a low rate of cholesterol synthesis and 
rely predominantly on the LDLR pathway for their cholesterol needs. 
Synthesis of LDLR should be fine tuned by feedback inhibition of 
intracellular cholesterol. LDLR gene expression was demonstrated by 
Auwerx et al (1989a) to be under the control of protein kinase C (PKC) 
and a labile negative regulatory protein. This second messenger 
system generally promotes nuclear and cytoplasmic events leading 
eventually to cell proliferation and differentiation. 
To gain further insights into the regulation of R2-BF expression, 
the effects of several compounds which selectively 1) activate PKC 
(PMA), 2) increase intracellular cAMP concentration (dbCAMP), 3) 
inhibits general protein synthesis (cycloheximide) and 4) prevent 
recycling of LDLR (monensin) were investigated. The results are 
depicted in Figure 3.14. R2-BF could be suppressed by 3 hour 
treatment with PMA, cycloheximide and monensin while dbCAMP 
produced no effect. These results suggest that protein synthesis and 
protein kinase C play a role in the control of expression of R2-BF. 
Our findings confirm the previous work of Auwerx et al, (1989) 
who tested LDLR bearing cells with the above drugs. They 
demonstrated an increase of LDLR gene transcription in human skin 
fibroblast after 20 minutes incubation in cycloheximide and one hour 
incubation in PMA. The 20 minute cycloheximide treatment suggests 
that the inhibition of protein synthesis may affect a liable negatively 
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regulatory protein which is involved in governing the expression of 
LDLR. The 3 hours PMA treatment shows that LDLR gene 
expression is also under the control of protein kinase C. 
Since there are several second-messenger pathways leading to 
protein phosphorylation, it is likely that the distinct phosphorylation 
events initiated by different messengers may overlap at one or several 
points, resulting in cross-talk between the different systems. A 
negatively regulatory protein is thought to interact with the Repeat 2 
region of the LDLR promoter and exerts its effect. Activation of 
transcription could then occur by converting it, possibly by PKC 
promoted phosphorylation, into a form unable to bind to the Repeat 2 
or activate another regulatory protein which may act indirectly on 
factors which can bind onto Repeat 2 (see Figure 4.1). 
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Proposed mechanism in LDLR regulation in HepG 2 cell 
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4.3.1.3 Effect of Shanzha 
The extracts from the fruit Crataegus pinnatifida. have been used 
extensively in China to facilitate digestion after a fatty meal. In recent 
years, the lipid lowering effect of this extract, commonly called 
Shanzha, was reported in a number of animal and clinical studies. 
Shanzha appears to block the down regulation of LDLR when elevated 
levels of the lipoprotein is present. The effect of Shanzha on the 
expression of the R2-BF is being studied in this thesis and the results 
are shown on Figure 3.15. Shanzha can totally suppress the expression 
of the R2-BF in HepG 2 cells. R2-BF is believed to be a liable 
negatively regulatory protein that can suppress the expression of the 
LDLR gene. When the expression of R2-BF is suppressed by 
treatment with Shanzha, the LDLR gene is no longer inhibited by R2-
BF and thus LDLR can express on the cell surface. This prediction 
was confirmed by 125 I _ l D L binding assay as Shanzha has a gross 
effect on up regulating the expression of LDLR, especially in the 
presence of L D L in the culture medium (Figure 3.8). The presence of 
R2-BF in HepG 2 cells is probably required to mediate the suppression 
of the LDLR gene and this effect can be totally inhibited by Shanzha. 
4.3.2 Screening of the cDNA library of HepG 2 cells 
We have performed several rounds of screening on a cDNA 
library from HepG 2 cells for R2-BF, but no positive clone was 
obtained. Our negative result may be attributed to several possibilities• 
Firstly, the 入 gt 11 expression vector cannot express the R2-BF so no 
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clone can be detected. Secondly, the conditions in screening require 
optimization in terms of salt concentration, the temperature used and 
the hybridization timing. And this may not have been optimal in the 




In order to obtain more insights on the role of R2-BF in the 
control of expression of the LDLR gene, R2-BF must be first isolated, 
purified and characterized. The classical isolation and purification 
process can be divided into two main directions. First of all, the 
screening of the cDNA expression library of HepG 2 cell by Repeat 2 
oligonucleotides wi l l need to be continued so as to clone the R2-BF 
gene. Secondly, by making use of Repeat 2 oligonucleotides to pack an 
affinity column in order to isolated the native R2-BF from the crude 
nuclear extracts directly. 
Since the suppressing effect of Shanzha on R2-BF and the up 
regulating effect of LDLR by Shanzha were identified, these effects of 
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GGATCCCACA AAACAAAAAA TATTTTTTTG GCTGTACTTT TGTGAAGATT TTATTTAAAT 
-627 
TCC今TGATTGA TCAGTGTCTA TTAGGTGATT TGGAATAACA ATGTAAAAAC AATATACAAC 
-567 
GAAAGGAAGC TAAAAATCTA TACACAATTC CTAGAAAGGA AAAGGCAAAT ATAGAAAGTG 
-507 
GCGGAAGTTC CCAACATTTT TAGTGTTTTC CTTTTGAGGC AGAGAGGACA ATGGCATTAG 
-447 
GCTATTGGAG GATCTTGAAA GGCTGTTGTT ATCCTTCTGT GGACAACAAC AGCAAAATGT 
-387 
TAACAGTTAA ACATCGAGAA ATTTCAGGAG GATCTTTCAG AAGATGCGTT TCCAATTTTG 
-327 
AGGGGGCGTC AGCTCTTCAC CGGAGACCCA AATACAACAA ATCAAGTCGC CTGCCCTGGC 
-267 
GACACTTTCG AAGGACTGGA GTGGGAATCA GAGCTTCACG GGTTAAAAGC CGATGTCACA 
-207 Repeat 1 Repeat 2 
TCGGCCGTTC GAAACTCCTC CTCTTGCAGT GAGGTGAAGA CATTTGAAAA TCACCCCACT 
-147 Repeat 3 TATA TATA 
GCAAACTCCT CCCCCTGCTA GAAACCTCAC ATTGAAATGC TGTAAATGAC GTGGGCCCCG 
-87 
AGTGCAATCG CGGGAAGCCA GGGTTTCCA务 G CTAGGACACA GCAGGTCGTG ATCCGGGTCG 
-27 +1 
GGACACTGCC TGGCAGAGGC TGCGAGCATG GGGCCCTGGG GCTGCAAATT GCGCTGGACC 
4 
GTCGCCTTGC TCCTCGCCGC GGCGGGGACT GCAGGTAAGG CTTGCTCCA 
I 
(LDLRP 687 BP DNA 5'-flanking region) 
(BASE COUNT 220 A 170 C 193 G 186 T) 
The whole sequence of LDLR promoter. It includes the three 
imperfect Repeats (Boldface) and two TATA-l ike sequence 
(Italic). The + 1 was assigned to transcription starting site ATG. 
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Procedure A: Preparation of oligo(dT)-CeIlulose 
• Approximately 20-30 minutes before the tissue or cell sample will be ready 
for extraction, remove the kit from storage at 
• Placed Extraction Buffer at 37^C until all crystalline material is dissolved. 
Cool to room temperature. 
• Gently swirl the Oligo(dT)-Cellulose slurry to obtain a uniform suspension. 
• Immediately pipette 1 mL aliquots of OIigo(dT)-Cenulose into individual 
microcentrifuge tubes for each purification to be performed. 
Procedure B: Extraction of Sample 
• Free adherent cells from anchorage by standard methodology and suspend 
them in a small volume of isotonic buffer. 
• Pellet 1 X 107 cells by centrifiigation and remove the supernatant. 
• Add 0.4 mL of Extraction Buffer to the pellet cells. Vortex until a 
homogeneous suspension is achieved. 
• Dilute the sample by adding 0.8 mL of Elution Buffer and mix using a 
vortex mixer. 
• Place 0.5 mL of Elution Buffer (per purification) at 65^C until needed in 
Procedure C. 
Procedure C: Isolation of mRNA 
Binding Step 
• Prepared a "cleared cellular homogenate" by centrifuging each extracted 
sample for 1 minutes at top speed. 
• Removed the buffer from the 01igo(dT)-CeIIuIose pellet. 
• Placed 1 mL of the clear cellular homogenate on the top of the pellet of 
01igo(dT)-CelIulose. 
• Closed the tube and invert to resuspend the 01igo(dT)-CeIlulose. 
• Gently mix for 3 minutes by inverting the tube manually. 
• Place the sample in the microcentrifuge and centrifuge for 10 minutes. 
• Remove the supernatant by pipette. 
Washing Step 
• Repeat the wash using High-Salt Buffer for a total of five washes 
• Repeat the wash using Low-Salt Buffer for a total of two washes. 
• Resuspend the resin in 0.3 mL Low-Salt Buffer and transfer the slurry to 
MicroSpin Column. Place in a microcentrifuge tube. 
• Place the column in the microcentrifuge and spin at full speed for 5 seconds. 
• Repeat washing by adding 0.5 mL Low-Salt Buffer to the column and spin at 
full speed for 5 seconds for a total of three washes. 
Elution Step 
• Remove the column and place it in a sterile microcentrifuge tube. 
• Add 0.2 mL of pre-warmed Elution Buffer to the top of the resin bed. 
• Centrifuge at top speed for 5 seconds and add a second 0.2 mL of aliquot of 
warm Elution Buffer to the top of the resin bed and centrifuge as described 
above. 
• Remove the column and place the tube containing the eluted mRNA on ice 




cDNA synthesis reactions 
• Place 5 |Lig of RNA in a microfuge tube and add water to make the volume 
up to 20 |liL. The diluted mRNA was then heated to 65^C for 10 minutes. 
The sample was chilled on ice. 
• The First-Strand Reaction Mix was spinned briefly. Add 1 [iL DTT 
Solution and 0.5 |ig/l pL Oligo(dT) and mix by pipetting up and down. The 
first-strand reaction mixture was then incubated at for one hour. 
• Spin the Second-Strand Reaction to collect the solution at the bottom. 
Transfer the first-strand reaction to this tube and mix gently. Incubated at 
120C for thirty minutes and at 22^C for one hour. 
• Heat at 65^C for 10 minutes and cooled down to room temperature to 
inactivate the enzyme participate in the cDNA generation. 
• Add 100 |liL of phenol/chloroform to the reaction mixture, mix by vortex and 
spin by microcentrifugation. The upper 100 [iL aqueous layer was removed 
and stored on ice. 
• Invert S-400 Spun Column to resuspend the Sephacryl® S-400 gel. The top 
and bottom cap of the column was then removed and allowed the buffer to 
drain. 
• Equilibrate the column with the 2 mL ligation buffer (66 mM Tris-HCl (pH 
7.6), 0.1 mM spermidine, 6.6 mM MgCl�，10 mM dithiothreitol (DTT), 150 
mM NaCl). Repeated twice in order to make sure that the gel matrix was 
equilibrated with ligation buffer. The bottom cap was then replaced to 
ensure the gel was wetted. 
• Place the column on the top a Corex® tube. The tube with spun column was 
subjected to centrifuge for 2 minutes at approximately 400 X g in a swing-
bucket rotor. 
• The aqueous portion of the extracted cDNA sample to the center of the flat 
surface at the top of the compact bed. Place a 1.5 mL microcentrifuge tube 
at the bottom of the Corex®tube. Spin the whole setup carefully for 2 
minutes at approximately 400 X g in a swing-bucket rotor. 
• Discard the column and the effluent collected in the microcentrifuge tube was 
placed at 
• Dilute 1 |iL ATP-Solution diluted with 4 |iL RNase-free Water. Add 5 i^L 
EcoR I/Not I Adapter Solution, 30 i^ L PEG buffer, 1 fiL diluted ATP-
Solution and 1 |liL of T4 DNA ligase to the spun column effluent C 100 |liL). 
The whole reaction mixture was incubated at 16®C for one hour. 
• The reaction mixture was heated at 65^C for 10 minutes to denature the 
DNA Ligase, then chilled on ice. 
• Add 1.5 |liL ATP-Solution and 1 [iL of T4 Polynucleotide Kinase and the 
reaction mixture was incubated at 37®C for 30 minutes. 
• Heat the reaction at 65^C for 10 minutes and cool to room temperature. 
• Add 140 |iL of phenol/chloroform and vortex to mix. The upper aqueous 
layer was obtained by centrifugation for at least one minute in 
microcentrifuge. 
• Apply the upper aqueous (140 - 150 nL) layer to the Spun Column as 
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